Vidarabine
| Title | Journal |
|---|---|
| Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. | Toxicology letters 20150105 |
| The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells. | Leukemia 20150101 |
| Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide. | PloS one 20140101 |
| A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia. | Cancer treatment reviews 20121201 |
| Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China. | Medical oncology (Northwood, London, England) 20121201 |
| Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121101 |
| Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype. | Leukemia & lymphoma 20121101 |
| [Detection and impact of minimal residual disease on outcome of chronic lymphocytic leukemia]. | Orvosi hetilap 20121014 |
| The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells. | Investigational new drugs 20121001 |
| Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. | Bone marrow transplantation 20121001 |
| Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity. | Bone marrow transplantation 20121001 |
| Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group. | Leukemia & lymphoma 20121001 |
| N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity. | Leukemia 20121001 |
| Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes. | Ophthalmology 20121001 |
| Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity. | Journal of proteome research 20120907 |
| Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide. | Medical oncology (Northwood, London, England) 20120901 |
| Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment. | Medical oncology (Northwood, London, England) 20120901 |
| Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning. | Bone marrow transplantation 20120901 |
| Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival. | Bone marrow transplantation 20120901 |
| A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita. | Bone marrow transplantation 20120901 |
| Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study. | Leukemia & lymphoma 20120901 |
| Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120901 |
| Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. | Haematologica 20120901 |
| A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. | Annals of hematology 20120901 |
| Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma. | American journal of hematology 20120901 |
| Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis. | Leukemia research 20120901 |
| Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia. | Pediatric hematology and oncology 20120901 |
| Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma Foundation. | Cancer 20120815 |
| ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. | Blood 20120809 |
| Treatment of older patients with mantle-cell lymphoma. | The New England journal of medicine 20120809 |
| Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertension. | Prostaglandins & other lipid mediators 20120801 |
| Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant. | Leukemia & lymphoma 20120801 |
| Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia. | Clinical lymphoma, myeloma & leukemia 20120801 |
| Adiponectin inhibits the generation of reactive oxygen species induced by high glucose and promotes endothelial NO synthase formation in human mesangial cells. | Molecular medicine reports 20120801 |
| Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120801 |
| Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak. | Cell death & disease 20120801 |
| Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. | Blood 20120712 |
| Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710 |
| [Modern times: back to past, back to future]. | Medicina clinica 20120707 |
| The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease. | Leukemia & lymphoma 20120701 |
| Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial. | Leukemia & lymphoma 20120701 |
| Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701 |
| Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. | Annals of hematology 20120701 |
| Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study. | Journal of cancer research and clinical oncology 20120701 |
| Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells. | Biochemical pharmacology 20120701 |
| Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701 |
| miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. | Carcinogenesis 20120701 |
| Sequential arabinosylcytosin with or without fludarabine in paracmastic patients with acute myeloid leukemia. | Die Pharmazie 20120701 |
| T-cell large granular lymphocytic leukemia: treatment experience with fludarabine. | Clinics (Sao Paulo, Brazil) 20120701 |
| Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase. | American journal of physiology. Heart and circulatory physiology 20120615 |
| Lytic bone disease as the presenting feature of Philadelphia-positive monosomy 7 myelodysplasia progressing to acute myeloid leukaemia. | Gene 20120615 |
| S-Adenosylhomocysteine hydrolase of the protozoan parasite Trichomonas vaginalis: potent inhibitory activity of 9-(2-deoxy-2-fluoro-β,D-arabinofuranosyl)adenine. | Bioorganic & medicinal chemistry letters 20120615 |
| A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia. | Investigational new drugs 20120601 |
| Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120601 |
| Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells. | Haematologica 20120601 |
| Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells. | Haematologica 20120601 |
| Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism. | Pediatric transplantation 20120601 |
| T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies. | British journal of haematology 20120601 |
| Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis. | American journal of hematology 20120601 |
| Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53. | Proteomics. Clinical applications 20120601 |
| Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial. | Blood 20120531 |
| Risk categories and refractory CLL in the era of chemoimmunotherapy. | Blood 20120503 |
| Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT. | Bone marrow transplantation 20120501 |
| Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. | Bone marrow transplantation 20120501 |
| Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide. | Annals of hematology 20120501 |
| Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant. | Leukemia & lymphoma 20120501 |
| The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature. | Leukemia & lymphoma 20120501 |
| Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells. | Leukemia & lymphoma 20120501 |
| Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemia. | Leukemia 20120501 |
| Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. | Naunyn-Schmiedeberg's archives of pharmacology 20120501 |
| Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys. | Molecular therapy : the journal of the American Society of Gene Therapy 20120501 |
| The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT. | Bone marrow transplantation 20120501 |
| Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. | Blood reviews 20120501 |
| The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells. | Oncotarget 20120501 |
| Fludarabine may overcome resistance to rituximab in IgM-related neuropathy. | Journal of the neurological sciences 20120415 |
| Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation. | Bone marrow transplantation 20120401 |
| The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120401 |
| LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism. | Leukemia research 20120401 |
| Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients. | Journal of immunology (Baltimore, Md. : 1950) 20120401 |
| FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients. | Journal of pediatric hematology/oncology 20120401 |
| Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia. | Blood 20120329 |
| Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. | Blood 20120322 |
| Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120320 |
| Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120310 |
| Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning. | Bone marrow transplantation 20120301 |
| FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame. | Hematological oncology 20120301 |
| The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study. | Hematological oncology 20120301 |
| Successful cord blood transplantation with reduced-intensity conditioning for childhood cerebral X-linked adrenoleukodystrophy at advanced and early stages. | Pediatric transplantation 20120301 |
| Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand? | Leukemia & lymphoma 20120301 |
| Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results. | Leukemia & lymphoma 20120301 |
| Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia. | Leukemia & lymphoma 20120301 |
| Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia. | Leukemia & lymphoma 20120301 |
| Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120301 |
| Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation. | Haematologica 20120301 |
| Fludarabine and rituximab for relapsed or refractory hairy cell leukemia. | Blood 20120301 |
| Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia. | American journal of hematology 20120301 |
| Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). | Annals of oncology : official journal of the European Society for Medical Oncology 20120301 |
| Herpes simplex virus 2 infection rate and necessity of screening during pregnancy: a clinical and seroepidemiologic study. | Yonsei medical journal 20120301 |
| Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. | Nature cell biology 20120301 |
| Feasibility of non-TBI conditioning with busulfan and fludarabine for allogeneic stem cell transplantation in lymphoid malignancy. | The Korean journal of internal medicine 20120301 |
| [Allogeneic hematopoietic stem cell transplantation with fludarabine, melphalan, and total body irradiation as a conditioning for elderly patients with myeloid malignancies]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20120301 |
| Antiviral activities and putative identification of compounds in microbial extracts from the Hawaiian coastal waters. | Marine drugs 20120301 |
| Alemtuzumab for patients with chronic lymphocytic leukaemia. | The Cochrane database of systematic reviews 20120215 |
| Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR. | Bone marrow transplantation 20120201 |
| Recurrent Kaposi's varicelliform eruption successfully controlled by low-dose oral valaciclovir. | The Journal of dermatology 20120201 |
| Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantation. | Bone marrow transplantation 20120201 |
| A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20120201 |
| Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility. | Annals of hematology 20120201 |
| Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201 |
| Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study. | Cancer chemotherapy and pharmacology 20120201 |
| Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia. | Leukemia & lymphoma 20120201 |
| Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia. | Leukemia & lymphoma 20120201 |
| Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44. | Journal of clinical immunology 20120201 |
| CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study. | Haematologica 20120201 |
| Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders. | Clinical lymphoma, myeloma & leukemia 20120201 |
| Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201 |
| Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20120201 |
| Individualized fludarabine-based regimen in elderly patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. | Advances in therapy 20120201 |
| Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. | The Journal of biological chemistry 20120120 |
| Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease. | Cancer 20120115 |
| Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120115 |
| Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120115 |
| Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas. | Bone marrow transplantation 20120101 |
| Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study. | Bone marrow transplantation 20120101 |
| Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin. | Leukemia & lymphoma 20120101 |
| Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials. | Leukemia & lymphoma 20120101 |
| Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia. | Leukemia & lymphoma 20120101 |
| FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment. | American journal of hematology 20120101 |
| Low incidence and severity of oral mucositis in allogeneic stem cell transplantation after conditioning with treosulfan and fludarabine. | European journal of haematology 20120101 |
| [Neonatal herpes simplex type II virus infection complicated with meningitis and virus-associated hemophagocytic syndrome]. | Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 20120101 |
| Does fludarabine increase the incidence of sinusoidal obstruction syndrome when combined with Bu/Cy during conditioning? | Clinical transplantation 20120101 |
| The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes. | PloS one 20120101 |
| Cytotoxic, virucidal, and antiviral activity of South American plant and algae extracts. | TheScientificWorldJournal 20120101 |
| Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study. | Pharmacological reports : PR 20120101 |
| Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. | PloS one 20120101 |
| A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data. | PloS one 20120101 |
| The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation. | International journal of hepatology 20120101 |
| Epstein-Barr virus-negative classical Hodgkin's lymphoma in a patient with T-cell prolymphocytic leukemia treated with fludarabine. | Journal of clinical and experimental hematopathology : JCEH 20120101 |
| Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma. | BMJ case reports 20120101 |
| Pharmacological stimulation of type 5 adenylyl cyclase stabilizes heart rate under both microgravity and hypergravity induced by parabolic flight. | Journal of pharmacological sciences 20120101 |
| Successful treatment of γ-heavy-chain disease with rituximab and fludarabine. | Acta haematologica 20120101 |
| Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. | Blood 20111222 |
| Chemotherapy: New FluCam combination therapy has familiar limitations. | Nature reviews. Clinical oncology 20111206 |
| FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia. | Medical oncology (Northwood, London, England) 20111201 |
| Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID. | Bone marrow transplantation 20111201 |
| Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party. | Bone marrow transplantation 20111201 |
| Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning. | Hematological oncology 20111201 |
| Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy. | Scandinavian journal of urology and nephrology 20111201 |
| Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma. | Clinical lymphoma, myeloma & leukemia 20111201 |
| IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. | The Journal of investigative dermatology 20111201 |
| Gastric mucosa-associated lymphoid tissue lymphoma: how to attack the T… for two? | Leukemia & lymphoma 20111201 |
| A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma. | Clinical lymphoma, myeloma & leukemia 20111201 |
| Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment. | Leukemia & lymphoma 20111201 |
| The effects of chemotherapeutic agents on differentiated chordoma cells. | Journal of neurosurgery. Spine 20111201 |
| Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial. | The Lancet. Oncology 20111201 |
| Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome. | The American Journal of dermatopathology 20111201 |
| Fludarabine nucleoside modulates nuclear 'survival and death' proteins in resistant chronic lymphocytic leukemia cells. | Nucleosides, nucleotides & nucleic acids 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Progressive multifocal leukoencephalopathy following fludarabine treatment in a chronic lymphocytic leukemia patient. | Experimental oncology 20111201 |
| Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia. | Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20111201 |
| Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort. | Cancer 20111115 |
| Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study. | Blood 20111110 |
| Anti-CD20: tales of identical twins? | Blood 20111110 |
| Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. | JAMA 20111102 |
| Overcoming the age barrier in hematopoietic stem cell transplantation: progress, but still a long way to go. | JAMA 20111102 |
| Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors. | International journal of radiation oncology, biology, physics 20111101 |
| Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes. | Bone marrow transplantation 20111101 |
| Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111101 |
| Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia. | European journal of haematology 20111101 |
| Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. | Clinical immunology (Orlando, Fla.) 20111101 |
| Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. | Journal of medical virology 20111101 |
| Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study. | Cytometry. Part B, Clinical cytometry 20111101 |
| Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells. | Clinical and experimental immunology 20111101 |
| Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma. | Journal of pediatric surgery 20111101 |
| [Clinical study of kangai injection plus FLAG regimen for refractory/relapsed acute leukemia]. | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20111101 |
| An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia. | Blood 20111013 |
| Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4). | Bone marrow transplantation 20111001 |
| Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001 |
| Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001 |
| Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab. | Annals of hematology 20111001 |
| Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia. | Leukemia & lymphoma 20111001 |
| Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis. | Leukemia & lymphoma 20111001 |
| Treatment strategies in patients with core-binding factor acute myeloid leukemia. | Current oncology reports 20111001 |
| A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. | British journal of haematology 20111001 |
| Unrepairable DNA double-strand breaks initiate cytotoxicity with HSV-TK/ganciclovir. | Cancer gene therapy 20111001 |
| Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia. | International journal of hematology 20111001 |
| Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. | Blood 20110929 |
| Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. | Blood 20110922 |
| Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110910 |
| A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients. | Cancer chemotherapy and pharmacology 20110901 |
| Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901 |
| Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901 |
| Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial. | Haematologica 20110901 |
| Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome. | Blood 20110901 |
| Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. | British journal of haematology 20110901 |
| Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trial. | Expert review of anticancer therapy 20110901 |
| Comment on research report by Gruson and colleagues, this issue. | Journal of the peripheral nervous system : JPNS 20110901 |
| Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy. | Journal of the peripheral nervous system : JPNS 20110901 |
| [Study on the chemical constituents of Phryma leptostachya]. | Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20110901 |
| Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. | Blood 20110825 |
| Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia. | Blood 20110825 |
| Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia. | Blood 20110825 |
| Alternative donor marrow transplantation in children with aplastic anemia using low-dose irradiation and fludarabine-based conditioning. | Bone marrow transplantation 20110801 |
| Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG. | Bone marrow transplantation 20110801 |
| Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801 |
| NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801 |
| A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies. | Annals of oncology : official journal of the European Society for Medical Oncology 20110801 |
| Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: a remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD). | Pediatric blood & cancer 20110801 |
| Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110801 |
| Armed and targeted measles virus for chemovirotherapy of pancreatic cancer. | Cancer gene therapy 20110801 |
| Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis. | Leukemia research 20110801 |
| Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801 |
| Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110801 |
| [The comparison of fludarabine or antithymocyte globulin based non-myeloablative conditioning regimen for haematologic diseases with graft-versus-host disease]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110801 |
| ⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma. | Blood 20110728 |
| Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110715 |
| Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells. | American journal of respiratory cell and molecular biology 20110701 |
| High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701 |
| Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701 |
| Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701 |
| Unrelated donor transplantation for acute myelogenous leukemia in first remission. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701 |
| Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma. | Annals of hematology 20110701 |
| Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy. | Leukemia research 20110701 |
| Targeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic 'sensor/effector' compounds. | Leukemia & lymphoma 20110701 |
| New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia. | American journal of hematology 20110701 |
| A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction. | British journal of haematology 20110701 |
| Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir. | Bioorganic & medicinal chemistry letters 20110701 |
| Rituximab in chronic lymphocytic leukemia. | Advances in therapy 20110701 |
| Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia. | Blood 20110616 |
| [Practical considerations and questions in the treatment of chronic lymphocytic leukemia]. | Orvosi hetilap 20110612 |
| AMP-activated protein kinase attenuates Wnt/β-catenin signaling in human osteoblastic Saos-2 cells. | Molecular and cellular endocrinology 20110606 |
| A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents. | Bone marrow transplantation 20110601 |
| Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601 |
| Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601 |
| Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601 |
| CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL. | Leukemia research 20110601 |
| STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion. | American journal of physiology. Cell physiology 20110601 |
| Purine analog toxicity in patients with hairy cell leukemia. | Leukemia & lymphoma 20110601 |
| Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110601 |
| Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma. | American journal of hematology 20110601 |
| Allogeneic stem cell transplantation in follicular lymphoma. | Best practice & research. Clinical haematology 20110601 |
| Fludarabine versus chlorambucil: is the debate over? | Clinical lymphoma, myeloma & leukemia 20110601 |
| Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. | Journal of immunology (Baltimore, Md. : 1950) 20110515 |
| Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse. | Cancer 20110515 |
| Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances. | Antiviral chemistry & chemotherapy 20110512 |
| Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement. | International journal of radiation oncology, biology, physics 20110501 |
| Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia. | International journal of cancer 20110501 |
| Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases. | Bone marrow transplantation 20110501 |
| EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. | Bone marrow transplantation 20110501 |
| Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. | Bone marrow transplantation 20110501 |
| Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT. | Bone marrow transplantation 20110501 |
| Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity. | Bone marrow transplantation 20110501 |
| Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501 |
| Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501 |
| Diagnostic and therapeutic challenges. | Retina (Philadelphia, Pa.) 20110501 |
| The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501 |
| EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab. | Journal of neurology 20110501 |
| [Specific palatal infiltration in B-cell chronic lymphocytic leukemia]. | Actas dermo-sifiliograficas 20110501 |
| How I manage cold agglutinin disease. | British journal of haematology 20110501 |
| Prognostic value of the International Scoring System and response in patients with advanced Waldenstrom macroglobulinemia. | Haematologica 20110501 |
| Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20110501 |
| Fludarabine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma: high efficacy may come at a cost? | Leukemia & lymphoma 20110501 |
| Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors. | American journal of hematology 20110501 |
| Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK. | Health technology assessment (Winchester, England) 20110501 |
| Phyllanthus species for chronic hepatitis B virus infection. | The Cochrane database of systematic reviews 20110413 |
| Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation. | Bone marrow transplantation 20110401 |
| Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma. | Leukemia research 20110401 |
| Further evidences for pharmacogenetic assessment of nucleoside analogue-treated patients. | Leukemia research 20110401 |
| Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia. | Leukemia & lymphoma 20110401 |
| Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110401 |
| Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation. | International journal of hematology 20110401 |
| Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL. | Blood 20110317 |
| Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. | Journal of proteome research 20110304 |
| Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301 |
| Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301 |
| Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL). | Annals of hematology 20110301 |
| APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells. | European journal of haematology 20110301 |
| Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines. | Biochemical pharmacology 20110301 |
| A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. | British journal of haematology 20110301 |
| Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03). | Leukemia & lymphoma 20110301 |
| Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia. | Journal of pediatric hematology/oncology 20110301 |
| Early initial therapy of advanced follicular lymphoma: the need for vigilance. | Leukemia & lymphoma 20110301 |
| Twelfth biannual report of the Cochrane Haematological Malignancies Group--focus on tyrosine kinase inhibitors. | Journal of the National Cancer Institute 20110216 |
| ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia. | Oncogene 20110210 |
| Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia. | Annals of hematology 20110201 |
| Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. | Haematologica 20110201 |
| Alloreactive natural killer cells promote haploidentical hematopoietic stem cell transplantation by expansion of recipient-derived CD4(+) CD25(+) regulatory T cells. | Transplant international : official journal of the European Society for Organ Transplantation 20110201 |
| The RNA activator ds-p21 potentiates the cytotoxicity induced by fludarabine in Dohh2 cells. | Oligonucleotides 20110201 |
| Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications. | International journal of hematology 20110201 |
| Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning. | Leukemia & lymphoma 20110201 |
| Personalizing treatment for chronic lymphocytic leukemia. | Expert review of hematology 20110201 |
| Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia. | Expert review of anticancer therapy 20110201 |
| [A preliminary study on efficacy of allogeneic hematopoietic stem cell transplantation by myeloablative conditioning regimen with fludarabine for high risk leukemia patients]. | Zhongguo shi yan xue ye xue za zhi 20110201 |
| [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110201 |
| The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling. | Biochemical pharmacology 20110115 |
| Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells. | Blood 20110113 |
| Synthesis and biological properties of the cytotoxic 14-membered macrolides aspergillide A and B. | Chemistry (Weinheim an der Bergstrasse, Germany) 20110110 |
| Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies. | Blood 20110106 |
| Mumijo traditional medicine: fossil deposits from antarctica (chemical composition and beneficial bioactivity). | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT. | Bone marrow transplantation 20110101 |
| High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation. | Bone marrow transplantation 20110101 |
| Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. | Bone marrow transplantation 20110101 |
| Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan elimination. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110101 |
| Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome. | Annals of hematology 20110101 |
| Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia. | Cancer immunology, immunotherapy : CII 20110101 |
| Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia. | Leukemia & lymphoma 20110101 |
| Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia. | Journal of medical microbiology 20110101 |
| Enhancement of drug solubility and absorption by copolymers of 2-methacryloyloxyethyl phosphorylcholine and n-butyl methacrylate. | Drug metabolism and pharmacokinetics 20110101 |
| Neonatal herpes simplex virus infections: where are we now? | Advances in experimental medicine and biology 20110101 |
| U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia. | The oncologist 20110101 |
| A transient IgE monoclonal protein in a child. | Annals of clinical biochemistry 20110101 |
| FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90Yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases. | Journal of experimental & clinical cancer research : CR 20110101 |
| [FLAG regimen in the treatment of refractory and relapsed acute myeloid leukemia]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110101 |
| [Efficacy of chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110101 |
| Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation. | Journal of hematology & oncology 20110101 |
| [Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia]. | Gaceta sanitaria 20110101 |
| Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab. | BMC nephrology 20110101 |
| Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. | Neoplasma 20110101 |
| Systematic approaches towards the development of host-directed antiviral therapeutics. | International journal of molecular sciences 20110101 |
| Herpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosa. | PloS one 20110101 |
| Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen. | Medical science monitor : international medical journal of experimental and clinical research 20110101 |
| Atypical cytogenetics in therapy-related myelodysplastic syndrome secondary to indolent B-cell lymphoma. | Clinical laboratory science : journal of the American Society for Medical Technology 20110101 |
| Combination treatment of flag with non-pegylated liposomal doxorubicin (MYOCET(TM)) in elderly patients with acute myeloid leukemia: a single center experience. | International journal of immunopathology and pharmacology 20110101 |
| Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients. | Hematology/oncology and stem cell therapy 20110101 |
| Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation. | Onkologie 20110101 |
| Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells. | PloS one 20110101 |
| Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists. | PloS one 20110101 |
| Orbital apex syndrome associated with herpes zoster ophthalmicus. | Clinical ophthalmology (Auckland, N.Z.) 20110101 |
| The treatment of relapsed refractory chronic lymphocytic leukemia. | Hematology. American Society of Hematology. Education Program 20110101 |
| Combination therapies in ophthalmology: implications for intravitreal delivery. | Journal of ophthalmic & vision research 20110101 |
| Chemoenzymatic syntheses and anti-HIV-1 activity of glucose-nucleoside conjugates as prodrugs. | Bioconjugate chemistry 20101215 |
| Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. | Lancet (London, England) 20101211 |
| CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies. | Bone marrow transplantation 20101201 |
| Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics. | Gene therapy 20101201 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies. | Experimental hematology 20101201 |
| Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus. | Human pathology 20101201 |
| Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease. | Leukemia & lymphoma 20101201 |
| Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination. | Leukemia & lymphoma 20101201 |
| Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia. | Leukemia & lymphoma 20101201 |
| Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. | Leukemia 20101201 |
| Increasing the dose intensity of the conditioning regimen prior to allogeneic hematopoietic stem cell transplant: the role of pharmacokinetic monitoring. | Leukemia & lymphoma 20101201 |
| Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome. | Hematological oncology 20101201 |
| The European Medicines Agency review of ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukemia in patients refractory to fludarabine and alemtuzumab: summary of the scientific assessment of the European medicines agency committee for medicinal products for human use. | The oncologist 20101201 |
| DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells. | Experimental oncology 20101201 |
| [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation]. | Methods and findings in experimental and clinical pharmacology 20101201 |
| Effect of FCGR2A and FCGR3A variants on CLL outcome. | Blood 20101118 |
| Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells. | Annals of hematology 20101101 |
| Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. | The Journal of allergy and clinical immunology 20101101 |
| Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101101 |
| B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells. | Leukemia 20101101 |
| A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL. | Leukemia 20101101 |
| Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients. | Leukemia & lymphoma 20101101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk? | Leukemia & lymphoma 20101101 |
| Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institution. | American journal of hematology 20101101 |
| Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation. | Transplantation proceedings 20101101 |
| Refractory chronic lymphocytic leukemia--new therapeutic strategies. | Oncotarget 20101101 |
| High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. | Blood 20101028 |
| Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. | Blood 20101021 |
| Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010 |
| TP53 mutation and survival in chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010 |
| Chronic lymphocytic leukaemia--moving towards cure? | Lancet (London, England) 20101002 |
| Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. | Lancet (London, England) 20101002 |
| Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101001 |
| HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus. | Journal of hepatology 20101001 |
| Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience. | Pediatric hematology and oncology 20101001 |
| The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies. | British journal of haematology 20101001 |
| Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients. | Leukemia & lymphoma 20101001 |
| Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemia. | Leukemia 20101001 |
| Current immunochemotherapy strategies in follicular lymphoma. | Advances in therapy 20101001 |
| What's new in Waldenström macroglobulinemia. | Leukemia & lymphoma 20101001 |
| Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia. | Leukemia & lymphoma 20101001 |
| Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. | Expert review of anticancer therapy 20101001 |
| The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche. | Health technology assessment (Winchester, England) 20101001 |
| Stem cell transplantation using non-myeloablative conditioning regimen with fludarabine for hematological malignancies. | Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20101001 |
| Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS). | Cancer 20100915 |
| Rapid vision loss associated with fludarabine administration. | Retina (Philadelphia, Pa.) 20100901 |
| U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100901 |
| Chemoimmunotherapy of chronic lymphocytic leukemia. | Nature reviews. Clinical oncology 20100901 |
| LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells. | Leukemia 20100901 |
| Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results. | American journal of hematology 20100901 |
| Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patients. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20100901 |
| Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities. | International journal of hematology 20100901 |
| Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients. | British journal of cancer 20100824 |
| Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia. | Blood 20100812 |
| Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL. | American journal of hematology 20100801 |
| Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia. | Bone marrow transplantation 20100801 |
| High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia. | European journal of cancer (Oxford, England : 1990) 20100801 |
| Auer rod-like inclusions in a low-grade B-cell leukemia. | Annals of diagnostic pathology 20100801 |
| [Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol]. | Orvosi hetilap 20100801 |
| Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: recent data from the Czech Leukemia Study Group for Life (CELL). | Clinical lymphoma, myeloma & leukemia 20100801 |
| Peripheral blasts on day 21 of induction chemotherapy in a patient with core binding factor acute myeloid leukemia: more than meets the eye. | Clinical lymphoma, myeloma & leukemia 20100801 |
| [Bone marrow failure due to telomere associated gene mutation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20100801 |
| Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis. | Blood 20100729 |
| Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. | European journal of pharmacology 20100725 |
| Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710 |
| Inhibition of STAT1 accelerates bone fracture healing. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20100701 |
| Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. | Leukemia research 20100701 |
| Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells. | Cancer investigation 20100701 |
| Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL. | European journal of haematology 20100701 |
| Rhodococcus equi pneumonia in a patient with fludarabine-treated chronic lymphocytic leukemia and CD4-lymphopenia. | The American journal of the medical sciences 20100701 |
| Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy. | Leukemia 20100701 |
| Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options. | Leukemia & lymphoma 20100701 |
| Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies. | Environmental and molecular mutagenesis 20100701 |
| Ofatumumab in the treatment of chronic lymphocytic leukemia. | Drugs of today (Barcelona, Spain : 1998) 20100701 |
| New trends in nucleoside biotechnology. | Acta naturae 20100701 |
| HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning. | Blood 20100624 |
| T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience. | Medical oncology (Northwood, London, England) 20100601 |
| Aggregation of spectrin and PKCtheta is an early hallmark of fludarabine/mitoxantrone/dexamethasone-induced apoptosis in Jurkat T and HL60 cells. | Molecular and cellular biochemistry 20100601 |
| Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100601 |
| The odyssey of marine pharmaceuticals: a current pipeline perspective. | Trends in pharmacological sciences 20100601 |
| Regulatory T cell as a target for cancer therapy. | Archivum immunologiae et therapiae experimentalis 20100601 |
| Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. | Haematologica 20100601 |
| Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy. | Muscle & nerve 20100601 |
| [Research advance on fludarabine resistance mechanisms in chronic lymphocytic leukemia cells]. | Zhongguo shi yan xue ye xue za zhi 20100601 |
| Historical perspectives in the development of antiviral agents against poxviruses. | Viruses 20100601 |
| Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510 |
| Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants. | Bone marrow transplantation 20100501 |
| Post-transplant lymphoproliferative disorder following cytomegalovirus reactivation in a lung recipient. | General thoracic and cardiovascular surgery 20100501 |
| All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanism. | The Journal of biological chemistry 20100430 |
| Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100410 |
| A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma. | Biomedical chromatography : BMC 20100401 |
| [Brucella bacteremia reactivation 70 years after the primary infection]. | Medecine et maladies infectieuses 20100401 |
| Allogenic bone marrow transplantation with fludarabine/busulfan16 conditioning regimen and dasatinib maintenance therapy for elderly Philadelphia-positive acute/advanced leukemia patients. | Leukemia research 20100401 |
| Keratotic vascular papules over the feet: a case of Waldenström's macroglobulinaemia-associated cutaneous macroglobulinosis. | Clinical and experimental dermatology 20100401 |
| The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100401 |
| Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients. | American journal of hematology 20100401 |
| Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma. | American journal of hematology 20100401 |
| Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401 |
| Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401 |
| Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis. | American journal of hematology 20100401 |
| Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients. | Journal of pediatric hematology/oncology 20100401 |
| Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. | The Journal of allergy and clinical immunology 20100401 |
| Resistant herpes simplex keratitis. | Clinical & experimental ophthalmology 20100401 |
| [Female case of successful engraftment after PBSCT from her HLA-haploidentical son for severe aplastic anemia during maintenance peritoneal dialysis]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20100401 |
| HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer. | Bone marrow transplantation 20100301 |
| Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years. | Leukemia research 20100301 |
| Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. | Bone marrow transplantation 20100301 |
| Molecular identification of phaeohyphomycosis due to Alternaria infectoria in a patient with acute myeloid leukemia--a case report. | Diagnostic microbiology and infectious disease 20100301 |
| Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100301 |
| The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma. | European journal of haematology 20100301 |
| Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma. | British journal of haematology 20100301 |
| R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia. | Leukemia 20100301 |
| CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia. | Experimental hematology 20100301 |
| Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine. | Leukemia 20100301 |
| Natural pregnancy and delivery after unrelated bone marrow transplantation using fludarabine-based regimen in a Fanconi anemia patient. | International journal of hematology 20100301 |
| A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas. | Leukemia & lymphoma 20100301 |
| Clinical and imaging features of fludarabine neurotoxicity. | Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20100301 |
| NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220 |
| A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. | Blood 20100204 |
| Evidence of a clinical response at one yr after reduced-intensity allogeneic hematopoietic stem cell transplantation in heavily pretreated adolescents with aggressive refractory Hodgkin's lymphoma. | Pediatric transplantation 20100201 |
| Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen. | Bone marrow transplantation 20100201 |
| Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine. | Bone marrow transplantation 20100201 |
| The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20100201 |
| Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR). | British journal of haematology 20100201 |
| [Correlation of deoxycytidine kinase gene expression with fludarabine resistance in patients with chronic lymphocytic leukemia]. | Zhongguo shi yan xue ye xue za zhi 20100201 |
| Drug-induced immune hemolytic anemia. | Clinical advances in hematology & oncology : H&O 20100201 |
| Application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to different amine-containing drugs. | Journal of medicinal chemistry 20100128 |
| Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia. | Blood 20100121 |
| Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100120 |
| Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation. | Bone marrow transplantation 20100101 |
| Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT. | Bone marrow transplantation 20100101 |
| Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia. | Hemodialysis international. International Symposium on Home Hemodialysis 20100101 |
| Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia. | Leukemia 20100101 |
| Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate. | Biopharmaceutics & drug disposition 20100101 |
| R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. | Journal of cellular biochemistry 20100101 |
| Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation. | British journal of haematology 20100101 |
| Low-dose fludarabine increases rituximab cytotoxicity in B-CLL cells by triggering caspases activation in vitro. | Leukemia & lymphoma 20100101 |
| New agents for the treatment of genetically high-risk chronic lymphocytic leukemia. | Leukemia & lymphoma 20100101 |
| Novel therapeutic approaches in systemic lupus erythematosus. | Frontiers in bioscience (Scholar edition) 20100101 |
| Metabolic regulation of neuronal plasticity by the energy sensor AMPK. | PloS one 20100101 |
| Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature. | Dermatology (Basel, Switzerland) 20100101 |
| Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression. | Acta haematologica 20100101 |
| Severe pulmonary toxicity associated with fludarabine and possible contribution of rituximab. | Chemotherapy 20100101 |
| A rare occurrence of hairy cell leukemia in the Thai population: a case report. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20100101 |
| [Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphocytic leukemia]. | Terapevticheskii arkhiv 20100101 |
| Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. | PloS one 20100101 |
| Fludarabine-induced bradycardia in a patient with refractory leukemia. | Annals of Saudi medicine 20100101 |
| Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. | Molecular cancer 20100101 |
| MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. | Molecular cancer 20100101 |
| Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies. | Human antibodies 20100101 |
| Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients. | Cell transplantation 20100101 |
| Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men. | PloS one 20100101 |
| Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens. | PloS one 20100101 |
| Use of clofarabine for acute childhood leukemia. | Biologics : targets & therapy 20100101 |
| Immune hemolytic anemia associated with drug therapy. | Blood reviews 20100101 |
| Influence of perineurial cells and Toll-like receptors 2 and 9 on Herpes simplex type 1 entry to the central nervous system in rat encephalitis. | PloS one 20100101 |
| Topical ganciclovir in the treatment of acute herpetic keratitis. | Clinical ophthalmology (Auckland, N.Z.) 20100101 |
| Biclonal follicular lymphoma: histological, clinical and molecular characteristics. | Pathology 20100101 |
| A successfully treated case of herpes simplex encephalitis complicated by subarachnoid bleeding: a case report. | Journal of medical case reports 20100101 |
| Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia. | Frontiers in neuroanatomy 20100101 |
| Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia. | Journal of hematology & oncology 20100101 |
| Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita. | Acta haematologica 20100101 |
| Antiviral lead compounds from marine sponges. | Marine drugs 20100101 |
| Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. | The Cochrane database of systematic reviews 20100101 |
| Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome. | Blood 20091224 |
| Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. | Blood 20091217 |
| Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage. | Blood 20091217 |
| IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. | Annals of hematology 20091201 |
| Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia. | Bone marrow transplantation 20091201 |
| Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia. | Irish journal of medical science 20091201 |
| Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response. | British journal of haematology 20091201 |
| Adenosine2A receptors and epoxyeicosatrienoic acids: a recipe for salt and blood pressure regulation. | Hypertension (Dallas, Tex. : 1979) 20091201 |
| Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive. | Hypertension (Dallas, Tex. : 1979) 20091201 |
| Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab. | Journal of hepatology 20091201 |
| Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression. | Leukemia & lymphoma 20091201 |
| [FLAG regimen as consolidation therapy for patients with acute myeloid leukemia]. | Zhongguo shi yan xue ye xue za zhi 20091201 |
| In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia. | Internal medicine journal 20091201 |
| Innate and adaptive immune responses to herpes simplex virus. | Viruses 20091201 |
| Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. | Cancer 20091115 |
| Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2. | Bone marrow transplantation 20091101 |
| The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. | Leukemia 20091101 |
| Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients. | Experimental hematology 20091101 |
| 5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091101 |
| Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF. | American journal of hematology 20091101 |
| Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101 |
| Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101 |
| The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia. | Cancer research 20091101 |
| Identification of molecular targets for selective elimination of TRAIL-resistant leukemia cells. From spots to in vitro assays using TOP15 charts. | Proteomics 20091101 |
| Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20091101 |
| Synthesis of 2'-N-formamido nucleosides and biological evaluation. | Nucleosides, nucleotides & nucleic acids 20091101 |
| First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. | Blood 20091015 |
| Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma. | Cancer chemotherapy and pharmacology 20091001 |
| Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia. | Leukemia research 20091001 |
| Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia. | Leukemia 20091001 |
| Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study. | Leukemia 20091001 |
| Diagnosis by sheer coincidence. | The international journal of cardiovascular imaging 20091001 |
| Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma. | Cancer science 20091001 |
| Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma. | British journal of haematology 20091001 |
| Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer. | Pancreas 20091001 |
| Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival. | Leukemia & lymphoma 20091001 |
| FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience. | American journal of hematology 20091001 |
| Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091001 |
| Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way. | Leukemia & lymphoma 20091001 |
| The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial. | Leukemia & lymphoma 20091001 |
| Sequential adenovirus infection of type 14 hemorrhagic cystitis and type 35 generalized infection after cord blood transplantation. | International journal of hematology 20091001 |
| [Effect of FLAG consolidation therapy on mobilization of autologous peripheral blood stem cells in patients with acute myelogenous leukemia]. | Zhongguo shi yan xue ye xue za zhi 20091001 |
| [Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome]. | Zhongguo shi yan xue ye xue za zhi 20091001 |
| Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. | Leukemia & lymphoma 20091001 |
| p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy. | Leukemia & lymphoma 20091001 |
| Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature. | Tennessee medicine : journal of the Tennessee Medical Association 20091001 |
| Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. | Blood 20090924 |
| Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090920 |
| Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study. | Lancet (London, England) 20090912 |
| Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies. | Pediatric transplantation 20090901 |
| Chronic lymphocytic leukemia: treatment options for patients with refractory disease. | Cancer 20090901 |
| Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic? | British journal of haematology 20090901 |
| Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090901 |
| Rituximab for polyneuropathy with IgM monoclonal gammopathy. | Journal of neurology, neurosurgery, and psychiatry 20090901 |
| Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen. | Haematologica 20090901 |
| Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM. | Blood 20090820 |
| Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090820 |
| Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia. | Leukemia research 20090801 |
| Prognostic value of intrathecal antibody production and DNA viral load in cerebrospinal fluid of patients with herpes simplex encephalitis. | Journal of neurology 20090801 |
| Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide. | Leukemia & lymphoma 20090801 |
| Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide. | Annals of the New York Academy of Sciences 20090801 |
| [Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20090801 |
| [Conditioning regimen containing fludarabine instead of cyclophosphamide for haploidentical hematopoietic stem cell transplantation]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090801 |
| Efficacy of continuous acyclovir infusion in neonatal herpes virus encephalitis. | Neuropediatrics 20090801 |
| Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090715 |
| Antiviral agents for treatment of herpes simplex virus infection in neonates. | The Cochrane database of systematic reviews 20090708 |
| Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures. | Leukemia research 20090701 |
| Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. | Pediatric blood & cancer 20090701 |
| Novel therapies for peripheral T-cell non-Hodgkin's lymphomas. | Current opinion in hematology 20090701 |
| Treatment of fludarabine-refractory chronic lymphocytic leukemia. | Cancer 20090701 |
| Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. | Cancer research 20090701 |
| Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation. | Journal of pediatric hematology/oncology 20090701 |
| Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT. | Leukemia research 20090601 |
| The combined use of Flu/ATG in nonmyeloablative SCT for severe aplastic anemia with multiple earlier transfusions. | Bone marrow transplantation 20090601 |
| A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. | British journal of haematology 20090601 |
| Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090601 |
| The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia. | Journal of Korean medical science 20090601 |
| [Clinical study on fludarabine combined with cytarabine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia]. | Zhongguo shi yan xue ye xue za zhi 20090601 |
| Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia. | Current opinion in oncology 20090601 |
| Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia. | Health technology assessment (Winchester, England) 20090601 |
| Fludarabine and melphalan conditioning with tacrolimus as GVHD prophylaxis for allogeneic stem cell transplant recipients is an effective reduced-intensity combination regimen compared to the conventional regimen. | International journal of clinical oncology 20090601 |
| Pentostatin treatment combinations in chronic lymphocytic leukemia. | Clinical advances in hematology & oncology : H&O 20090601 |
| Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090601 |
| Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML. | Bone marrow transplantation 20090501 |
| Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD. | Bone marrow transplantation 20090501 |
| Oxidative stress and delta-ALA-D activity in different conditioning regimens in allogeneic bone marrow transplantation patients. | Clinical biochemistry 20090501 |
| Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation. | Pediatric blood & cancer 20090501 |
| A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma. | Leukemia 20090501 |
| Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma. | Cancer 20090501 |
| Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. | European journal of pharmacology 20090501 |
| Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20090501 |
| Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia. | Journal of clinical pathology 20090501 |
| Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia. | Blood 20090416 |
| Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens. | Blood 20090402 |
| The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia. | American journal of hematology 20090401 |
| Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon. | American journal of hematology 20090401 |
| Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. | The Lancet. Neurology 20090401 |
| Drug induction apoptosis assay as predictive value of chemotherapy response in patients with B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20090401 |
| [IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia]. | Zhongguo shi yan xue ye xue za zhi 20090401 |
| A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia. | Internal medicine journal 20090401 |
| A single apheresis procedure in the donor may be enough to complete an allograft using the 'Mexican method' of non-ablative allografting. | Blood transfusion = Trasfusione del sangue 20090401 |
| Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia. | Blood 20090319 |
| Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma. | Annals of hematology 20090301 |
| Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. | Leukemia 20090301 |
| Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. | Bone marrow transplantation 20090301 |
| Risk factors for polyoma virus nephropathy. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090301 |
| HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. | Microvascular research 20090301 |
| Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study. | American journal of hematology 20090301 |
| Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function. | American journal of hematology 20090301 |
| Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab. | Leukemia & lymphoma 20090301 |
| Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. | Leukemia & lymphoma 20090301 |
| Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemia. | Leukemia & lymphoma 20090301 |
| Assessment of bone marrow response in Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20090301 |
| Rituximab-based treatments in Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20090301 |
| Fludarabine-based combination therapies for Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20090301 |
| A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients. | Cancer chemotherapy and pharmacology 20090201 |
| Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia. | Leukemia research 20090201 |
| Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. | Annals of hematology 20090201 |
| Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro. | Journal of cancer research and clinical oncology 20090201 |
| Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator. | Leukemia 20090201 |
| Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine. | European journal of haematology 20090201 |
| Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201 |
| Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201 |
| Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201 |
| Design and synthesis of vidarabine prodrugs as antiviral agents. | Bioorganic & medicinal chemistry letters 20090201 |
| Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090201 |
| Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study. | Leukemia & lymphoma 20090201 |
| Alkylating agents for Waldenstrom's macroglobulinaemia. | The Cochrane database of systematic reviews 20090121 |
| Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090120 |
| Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090110 |
| Dasatinib induces a response in chronic lymphocytic leukemia. | Blood 20090108 |
| Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures. | Cancer chemotherapy and pharmacology 20090101 |
| A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia. | Annals of hematology 20090101 |
| Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. | Bone marrow transplantation 20090101 |
| AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. | Blood 20090101 |
| Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. | Immunologic research 20090101 |
| Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia. | Haematologica 20090101 |
| [First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment]. | Presse medicale (Paris, France : 1983) 20090101 |
| Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. | British journal of haematology 20090101 |
| Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG). | British journal of haematology 20090101 |
| Radiosensitization by inhibiting STAT1 in renal cell carcinoma. | International journal of radiation oncology, biology, physics 20090101 |
| 5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine. | Nucleosides, nucleotides & nucleic acids 20090101 |
| Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101 |
| Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101 |
| A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101 |
| Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen. | Cytotherapy 20090101 |
| Persistent hiccups as an adverse event to FLAG-IDA regimen for leukemia. | Acta oncologica (Stockholm, Sweden) 20090101 |
| Herpes zoster occurring as a solitary vesicular in malignant lymphoma. | European journal of dermatology : EJD 20090101 |
| Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma. | PloS one 20090101 |
| Chronic lymphocytic leukaemia: current first-line therapy. | Internal medicine journal 20090101 |
| Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections. | Clinical transplantation 20090101 |
| FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. | Immunologic research 20090101 |
| Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20090101 |
| Pulsed electromagnetic fields after arthroscopic treatment for osteochondral defects of the talus: double-blind randomized controlled multicenter trial. | BMC musculoskeletal disorders 20090101 |
| Update in the management of chronic lymphocytic leukemia. | Journal of hematology & oncology 20090101 |
| Long-lasting response of chronic lymphocytic leukemia and multiple sclerosis in a patient treated with oral fludarabine alone. | Tumori 20090101 |
| Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis. | Acta dermato-venereologica 20090101 |
| Comparative sequence and structural analyses of G-protein-coupled receptor crystal structures and implications for molecular models. | PloS one 20090101 |
| Acute lymphocytic crisis following herpes simplex type 1 virus hepatitis in a nonimmunocompromised man: a case report. | Journal of medical case reports 20090101 |
| Immune hemolytic anemia--selected topics. | Hematology. American Society of Hematology. Education Program 20090101 |
| State-of-the-art treatment of chronic lymphocytic leukemia. | Hematology. American Society of Hematology. Education Program 20090101 |
| Effect of combinations of antiviral drugs on herpes simplex encephalitis. | Drug design, development and therapy 20090101 |
| Infantile nonconvulsive status epilepticus caused by herpes encephalitis. | Journal of pediatric neurosciences 20090101 |
| The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081215 |
| A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia. | Pediatric transplantation 20081201 |
| Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years. | Leukemia research 20081201 |
| Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia. | Hematological oncology 20081201 |
| Massive swelling of the cervical region: an uncommon manifestation of B cell chronic lymphocytic leukemia. | Oral and maxillofacial surgery 20081201 |
| Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose. | Bone marrow transplantation 20081201 |
| 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. | Bone marrow transplantation 20081201 |
| Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats. | American journal of physiology. Renal physiology 20081201 |
| Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival. | Cancer 20081201 |
| Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells. | Haematologica 20081201 |
| Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro. | British journal of haematology 20081201 |
| Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. | Molecular cancer research : MCR 20081201 |
| Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110 |
| Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells. | Mutation research 20081110 |
| Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes. | Molecular and cellular endocrinology 20081106 |
| Kaposi's varicelliform eruption in a healthy adult. | The Medical journal of Australia 20081103 |
| Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration. | Annals of hematology 20081101 |
| Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization. | Leukemia 20081101 |
| Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. | Blood 20081101 |
| Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20081101 |
| Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases. | European journal of haematology 20081101 |
| p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. | Blood 20081101 |
| Images in haematology. Cerebral nocardiosis in a patient with lymphoplasmacytic lymphoma treated with fludarabine. | British journal of haematology 20081101 |
| Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia. | Leukemia 20081101 |
| Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy. | Haematologica 20081101 |
| Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101 |
| Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101 |
| Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. | British journal of haematology 20081101 |
| Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma. | European journal of medical research 20081027 |
| Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. | Transplantation 20081015 |
| Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients. | Cancer chemotherapy and pharmacology 20081001 |
| Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues. | Leukemia research 20081001 |
| Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone. | Leukemia & lymphoma 20081001 |
| [Chronic lymphocytic leukemia and the related disorders]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20081001 |
| Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions. | Molecular cancer therapeutics 20081001 |
| Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia. | Bone marrow transplantation 20081001 |
| Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. | Chinese medical journal 20080920 |
| Imatinib inhibition of fludarabine uptake in T-lymphocytes. | Cancer chemotherapy and pharmacology 20080901 |
| Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records. | Leukemia 20080901 |
| Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. | Blood 20080901 |
| Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients. | American journal of hematology 20080901 |
| Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease. | Haematologica 20080901 |
| Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia. | Current oncology reports 20080901 |
| Pentostatin in chronic lymphocytic leukemia. | Expert opinion on drug metabolism & toxicology 20080901 |
| Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080901 |
| Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience. | Pediatric transplantation 20080901 |
| Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. | Blood 20080815 |
| The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes. | Blood 20080815 |
| Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma. | Pharmacy world & science : PWS 20080801 |
| Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor. | American journal of hematology 20080801 |
| Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. | Bone marrow transplantation 20080801 |
| Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801 |
| Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801 |
| Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801 |
| [Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab]. | Zhongguo shi yan xue ye xue za zhi 20080801 |
| Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia. | Leukemia & lymphoma 20080801 |
| Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies. | Blood 20080715 |
| Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens. | Transplant infectious disease : an official journal of the Transplantation Society 20080701 |
| Successful bone marrow transplantation in a girl with Fanconi anemia and preterminal renal failure. | Bone marrow transplantation 20080701 |
| Comparable engraftment and chimerism kinetics using oral and intravenous fludarabine as part of a reduced intensity conditioning regimen. | Bone marrow transplantation 20080701 |
| Selective killing of Mycobacterium avium-infected macrophages by inhibition of phosphorylated signal transducer and activator of transcription type 1. | The Journal of infectious diseases 20080701 |
| Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403. | Haematologica 20080701 |
| Frontline therapy for chronic lymphocytic leukemia: the dilemma continues. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080701 |
| Induction of nucleoside phosphorylase in Enterobacter aerogenes and enzymatic synthesis of adenine arabinoside. | Journal of Zhejiang University. Science. B 20080701 |
| In hot water: global warming takes a toll on coral reefs. | Environmental health perspectives 20080701 |
| Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab. | Blood 20080615 |
| [Novel medical treatment modalities in hematology]. | Ugeskrift for laeger 20080609 |
| Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both? | Bone marrow transplantation 20080601 |
| Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies. | Cellular signalling 20080601 |
| Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma. | Leukemia 20080601 |
| Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia. | Leukemia & lymphoma 20080601 |
| HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601 |
| Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601 |
| Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601 |
| Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia. | British journal of haematology 20080601 |
| Non-MALT marginal zone lymphomas. | Annals of oncology : official journal of the European Society for Medical Oncology 20080601 |
| Fludarabine induces differential expression of proteins in human leukemia and lymphoma cells. | Nucleosides, nucleotides & nucleic acids 20080601 |
| Comparison of sensitivity of Escherichia coli WP2 tester strains with and without tolC outer membrane transport protein mutation in detecting chemical mutagens. | Journal of UOEH 20080601 |
| Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. | Journal of cellular biochemistry 20080515 |
| CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia. | Pediatric blood & cancer 20080501 |
| Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study. | Annals of hematology 20080501 |
| IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. | Blood 20080501 |
| A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation. | Bone marrow transplantation 20080501 |
| Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants. | Bone marrow transplantation 20080501 |
| Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13. | Journal of molecular medicine (Berlin, Germany) 20080501 |
| Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1. | Placenta 20080501 |
| Mutated and non-mutated TP53 as targets in the treatment of leukaemia. | British journal of haematology 20080501 |
| Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. | Experimental hematology 20080501 |
| Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20080501 |
| Regression of herpes viral infection symptoms using melatonin and SB-73: comparison with Acyclovir. | Journal of pineal research 20080501 |
| Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080501 |
| Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience. | International journal of hematology 20080501 |
| Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma. | Cancer investigation 20080501 |
| Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols. | Saudi medical journal 20080501 |
| Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia. | Leukemia & lymphoma 20080501 |
| Synthesis of 2'-([1,2,3]triazol-1-yl)-2'-deoxyadenosines. | Nucleosides, nucleotides & nucleic acids 20080501 |
| Liposomal coencapsulated fludarabine and mitoxantrone for lymphoproliferative disorder treatment. | Journal of pharmaceutical sciences 20080401 |
| Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia. | European journal of haematology 20080401 |
| High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan. | Bone marrow transplantation 20080401 |
| Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ). | The Lancet. Oncology 20080401 |
| Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401 |
| Antibody therapy for chronic lymphocytic leukemia. | Seminars in hematology 20080401 |
| Use of TAGVHD warnings in patients receiving purine analogue chemotherapy. | Transfusion medicine (Oxford, England) 20080401 |
| Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future. | Onkologie 20080401 |
| Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase. | Onkologie 20080401 |
| Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network. | Cancer 20080315 |
| Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080315 |
| Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. | Pediatric blood & cancer 20080301 |
| Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine. | Leukemia 20080301 |
| Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. | Leukemia 20080301 |
| Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. | Haematologica 20080301 |
| Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. | British journal of haematology 20080301 |
| Phase I trial of nelarabine in indolent leukemias. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301 |
| Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma. | Haematologica 20080301 |
| High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy. | Haematologica 20080301 |
| Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia. | Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20080301 |
| [Treatment of refractory severe autoimmune disease by combined therapy with Chinese drug and autohemopoietic stem cell transplantation]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080301 |
| Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei. | The Journal of biological chemistry 20080227 |
| The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. | Blood 20080215 |
| Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia. | Biochemical pharmacology 20080215 |
| A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma. | Cancer 20080215 |
| Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient. | Leukemia research 20080201 |
| Extramedullary, extranodal lymphoplasmacytic lymphoma with macroglobulinemia: long-term complete remission with fludarabine. | Annals of hematology 20080201 |
| Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. | International journal of radiation oncology, biology, physics 20080201 |
| Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. | Bone marrow transplantation 20080201 |
| Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. | Leukemia 20080201 |
| Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. | Cell death and differentiation 20080201 |
| Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. | Bone marrow transplantation 20080201 |
| Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. | Blood 20080201 |
| Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen. | Bone marrow transplantation 20080201 |
| Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines. | Blood 20080201 |
| Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients. | British journal of haematology 20080201 |
| Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia. | Pediatric transplantation 20080201 |
| Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201 |
| Invasive fungal sinusitis in patients treated with fludarabine. | The Journal of infection 20080201 |
| Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201 |
| High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201 |
| Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201 |
| Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience. | Haematologica 20080201 |
| Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. | Haematologica 20080201 |
| High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma. | Haematologica 20080201 |
| Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20080201 |
| Therapeutic interventions for herpes simplex virus epithelial keratitis. | The Cochrane database of systematic reviews 20080123 |
| BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism. | Blood 20080115 |
| Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells. | Transplantation 20080115 |
| Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110 |
| A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders. | Leukemia research 20080101 |
| Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. | Blood cells, molecules & diseases 20080101 |
| Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab. | Leukemia research 20080101 |
| Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. | Nature chemical biology 20080101 |
| A silkworm baculovirus model for assessing the therapeutic effects of antiviral compounds: characterization and application to the isolation of antivirals from traditional medicines. | The Journal of general virology 20080101 |
| Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080101 |
| Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia. | Medical oncology (Northwood, London, England) 20080101 |
| Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma. | Leukemia & lymphoma 20080101 |
| Waldenström macroglobulinemia of the orbit. | Ophthalmic plastic and reconstructive surgery 20080101 |
| Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation. | International journal of hematology 20080101 |
| Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico. | Pediatric hematology and oncology 20080101 |
| Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. | Virology journal 20080101 |
| Prodrug converting enzyme gene delivery by L. monocytogenes. | BMC cancer 20080101 |
| New advances in anti-HSV chemotherapy. | Current medicinal chemistry 20080101 |
| Paradoxical exacerbation of psoriasis during therapy with fludarabine. | European journal of dermatology : EJD 20080101 |
| Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes. | Pathobiology : journal of immunopathology, molecular and cellular biology 20080101 |
| Severe prolonged immunosuppression following fludarabine and rituximab combination therapy. | Chemotherapy 20080101 |
| Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia. | Anticancer research 20080101 |
| Normothermic treatment in acute clinical encephalitis: a case report. | Journal of medical case reports 20080101 |
| Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome. | Indian journal of ophthalmology 20080101 |
| Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. | Immunology and cell biology 20080101 |
| Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma. | American journal of clinical dermatology 20080101 |
| Collision induced dissociation studies of alkali metal adducts of tetracyclines and antiviral agents by electrospray ionization, hydrogen/deuterium exchange and multiple stage mass spectrometry. | European journal of mass spectrometry (Chichester, England) 20080101 |
| Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia. | European journal of dermatology : EJD 20080101 |
| Herpes simplex I encephalitis presenting as a brain haemorrhage with normal cerebrospinal fluid analysis: a case report. | Journal of medical case reports 20080101 |
| Fludarabine in lymphoproliferative malignancies: a single-centre experience. | The National medical journal of India 20080101 |
| Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia. | The Egyptian journal of immunology 20080101 |
| Have we forgotten the purpose of phase III studies? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071210 |
| Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning. | Leukemia 20071201 |
| Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. | Bone marrow transplantation 20071201 |
| Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. | Archives of biochemistry and biophysics 20071201 |
| Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071201 |
| Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo. | European journal of haematology 20071201 |
| Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071201 |
| Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes. | Leukemia & lymphoma 20071201 |
| [Effects of FLAG protocol in treatment of the first time induced non-remission acute myeloid leukemia]. | Zhongguo shi yan xue ye xue za zhi 20071201 |
| Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia. | Journal of Korean medical science 20071201 |
| Switching of donor cells after urgent second cord blood transplantation for suspected graft failure. | International journal of hematology 20071201 |
| Graft-versus-myeloma effects in reduced-intensity cord blood transplantation. | International journal of hematology 20071201 |
| Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes. | Clinical ophthalmology (Auckland, N.Z.) 20071201 |
| Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. | Cancer research 20071115 |
| Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia. | Blood 20071101 |
| Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan. | Bone marrow transplantation 20071101 |
| Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome. | Bone marrow transplantation 20071101 |
| Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine. | British journal of haematology 20071101 |
| Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. | Bone marrow transplantation 20071101 |
| Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia. | British journal of haematology 20071101 |
| Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071101 |
| Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis. | Experimental hematology 20071101 |
| Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy. | British journal of haematology 20071101 |
| [MALT (mucosa-associated lymphoid tissue) lymphoma of the lacrimal gland]. | Journal francais d'ophtalmologie 20071101 |
| Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG). | International journal of hematology 20071101 |
| [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment]. | Vnitrni lekarstvi 20071101 |
| Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. | Blood 20071015 |
| Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens. | Blood 20071015 |
| Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia. | Leukemia 20071001 |
| Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan. | American journal of hematology 20071001 |
| Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial. | American journal of hematology 20071001 |
| Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan. | Leukemia 20071001 |
| Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia. | Haematologica 20071001 |
| Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes. | British journal of haematology 20071001 |
| Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma. | British journal of haematology 20071001 |
| A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases. | British journal of haematology 20071001 |
| Chronic lymphocytic leukaemia resistant to both fludarabine and alemtuzumab--double jeopardy. | Leukemia & lymphoma 20071001 |
| The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy. | Leukemia & lymphoma 20071001 |
| Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia. | Leukemia & lymphoma 20071001 |
| Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. | The Netherlands journal of medicine 20071001 |
| [Curative efficacy of fludarabine combined with rituximab and amifostine on aged patient with B-chronic lymphocytic leukemia]. | Zhongguo shi yan xue ye xue za zhi 20071001 |
| [Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice]. | Zhongguo shi yan xue ye xue za zhi 20071001 |
| Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia. | International journal of hematology 20071001 |
| The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. | Haematologica 20071001 |
| Irreversible visual loss and optic nerve dysfunction associated with central retinal vein occlusion in Waldenstrom Macroglobulinemia. | The Medical journal of Malaysia 20071001 |
| Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma. | Current hematologic malignancy reports 20071001 |
| Graft versus host disease after stem cell allotransplantation with low-dose total body irradiation, fludarabine, and antithymocyte globulin. | Transplantation 20070915 |
| Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. | British journal of cancer 20070911 |
| Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs. | Gene therapy 20070901 |
| Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. | Bone marrow transplantation 20070901 |
| A comparison of G2 phase radiation-induced chromatid break kinetics using calyculin-PCC with those obtained using colcemid block. | Mutagenesis 20070901 |
| New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2. | Bone marrow transplantation 20070901 |
| Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070901 |
| Chemoimmunotherapy of chronic lymphocytic leukemia. | Best practice & research. Clinical haematology 20070901 |
| Minimal residual disease assessment in chronic lymphocytic leukaemia. | Best practice & research. Clinical haematology 20070901 |
| Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). | Pediatric hematology and oncology 20070901 |
| CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia. | British journal of haematology 20070901 |
| Fatal Epstein-Barr virus-associated lymphoproliferative disorder following treatment with a novel mTOR inhibitor for relapsed chronic lymphocytic leukemia leukemia cells. | Haematologica 20070901 |
| Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia. | Cancer genetics and cytogenetics 20070901 |
| Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues. | Experimental oncology 20070901 |
| [A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070901 |
| Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis. | Oncogene 20070823 |
| Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. | Blood 20070815 |
| Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine. | Annals of hematology 20070801 |
| Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation. | Annals of hematology 20070801 |
| Characterization of S-adenosylhomocysteine hydrolase from Cryptosporidium parvum. | FEMS microbiology letters 20070801 |
| Alkylator-free conditioning regimen for patients with acquired aplastic anemia, transplanted from genetically identical twins. | Pediatric transplantation 20070801 |
| Regurgitation of esophageal mucosa. | Mayo Clinic proceedings 20070801 |
| Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: spontaneous resolution upon cessation of fludarabine. | Leukemia & lymphoma 20070801 |
| Combination therapies for previously untreated CLL. | Lancet (London, England) 20070721 |
| Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. | Lancet (London, England) 20070721 |
| Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells. | British journal of cancer 20070716 |
| Fludarabine allows dose reduction for total body irradiation in pediatric hematopoietic stem cell transplantation. | International journal of radiation oncology, biology, physics 20070715 |
| T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years. | Leukemia research 20070701 |
| Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation. | Bone marrow transplantation 20070701 |
| Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia. | Bone marrow transplantation 20070701 |
| Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation. | Bone marrow transplantation 20070701 |
| Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients. | Bone marrow transplantation 20070701 |
| Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma. | Cancer 20070701 |
| Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070701 |
| Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070701 |
| Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. | Experimental hematology 20070701 |
| Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients. | British journal of haematology 20070701 |
| Rational design of inhibitors of VirA-VirG two-component signal transduction. | Bioorganic & medicinal chemistry letters 20070615 |
| Dictyostelium discoideum salvages purine deoxyribonucleosides by highly specific bacterial-like deoxyribonucleoside kinases. | Journal of molecular biology 20070608 |
| Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism. | American journal of hematology 20070601 |
| Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models. | Cancer chemotherapy and pharmacology 20070601 |
| Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation. | American journal of physiology. Heart and circulatory physiology 20070601 |
| Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis. | Rheumatology (Oxford, England) 20070601 |
| Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine. | International journal of oncology 20070601 |
| Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070601 |
| Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience. | Hematology (Amsterdam, Netherlands) 20070601 |
| The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome. | International journal of hematology 20070601 |
| Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. | Leukemia & lymphoma 20070601 |
| [Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20070601 |
| [Chronic lymphoid leukemia and intravenous immunoglobulins]. | La Revue de medecine interne 20070601 |
| Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia. | Oncogene 20070528 |
| Management of symptomatic, untreated chronic lymphocytic leukemia. | Blood reviews 20070501 |
| Drug resistance in B-cell chronic lymphocytic leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay. | Cytometry. Part B, Clinical cytometry 20070501 |
| Allogeneic bone marrow transplantation for Pearson's syndrome. | Bone marrow transplantation 20070501 |
| Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway. | Leukemia 20070501 |
| Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501 |
| A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia. | Journal of the American Academy of Dermatology 20070501 |
| A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070501 |
| Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia. | British journal of haematology 20070501 |
| In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation. | International journal of hematology 20070501 |
| Acquired hemophilia in chronic lymphocytic leukemia. | Leukemia & lymphoma 20070501 |
| Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. | Haematologica 20070501 |
| Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC). | Haematologica 20070501 |
| [Ulcers in a patient with chronic lymphocytic leukemia]. | Actas dermo-sifiliograficas 20070501 |
| Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas. | Cancer chemotherapy and pharmacology 20070401 |
| Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein. | Cancer immunology, immunotherapy : CII 20070401 |
| Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma. | Bone marrow transplantation 20070401 |
| Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases. | Bone marrow transplantation 20070401 |
| Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070401 |
| Current treatment options in prolymphocytic leukemia. | Medical science monitor : international medical journal of experimental and clinical research 20070401 |
| Gene expression signatures that predict radiation exposure in mice and humans. | PLoS medicine 20070401 |
| Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning. | Journal of Korean medical science 20070401 |
| Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation. | Hematology (Amsterdam, Netherlands) 20070401 |
| Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma. | Leukemia & lymphoma 20070401 |
| Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation. | International journal of hematology 20070401 |
| Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia. | Haematologica 20070401 |
| Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320 |
| Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia. | Leukemia research 20070301 |
| Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). | Leukemia 20070301 |
| Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy. | Leukemia 20070301 |
| Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia. | Clinical and experimental dermatology 20070301 |
| Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma. | Leukemia 20070301 |
| Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301 |
| Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated. | British journal of pharmacology 20070301 |
| Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients. | Transplant infectious disease : an official journal of the Transplantation Society 20070301 |
| Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301 |
| Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301 |
| Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation. | Haematologica 20070301 |
| Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors. | British journal of haematology 20070301 |
| Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience. | Leukemia & lymphoma 20070301 |
| Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case report. | World journal of gastroenterology 20070214 |
| Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice? | Leukemia research 20070201 |
| Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia. | Leukemia research 20070201 |
| F-ara-A pharmacokinetics during reduced-intensity conditioning therapy with fludarabine and busulfan. | Bone marrow transplantation 20070201 |
| Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. | Bone marrow transplantation 20070201 |
| Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial. | Bone marrow transplantation 20070201 |
| Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation. | Onkologie 20070201 |
| Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition? | European journal of haematology 20070201 |
| Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings. | European journal of haematology 20070201 |
| Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells. | International journal of hematology 20070201 |
| 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis. | Leukemia & lymphoma 20070201 |
| Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review. | Leukemia & lymphoma 20070201 |
| Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. | Haematologica 20070201 |
| Therapeutic interventions for herpes simplex virus epithelial keratitis. | The Cochrane database of systematic reviews 20070124 |
| Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient. | Leukemia research 20070101 |
| Preclinical assessment of curcumin as a potential therapy for B-CLL. | American journal of hematology 20070101 |
| Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. | Blood 20070101 |
| Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. | Annals of hematology 20070101 |
| STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. | International journal of cancer 20070101 |
| Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy. | British journal of haematology 20070101 |
| Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. | Journal of the American Academy of Dermatology 20070101 |
| Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia. | Bone marrow transplantation 20070101 |
| Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation. | Journal of clinical pharmacology 20070101 |
| Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. | British journal of haematology 20070101 |
| Double unrelated reduced-intensity umbilical cord blood transplantation in adults. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070101 |
| Improved outcome after relapse in children with acute myeloid leukaemia. | British journal of haematology 20070101 |
| Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma. | European journal of dermatology : EJD 20070101 |
| Advances in CLL. | Clinical advances in hematology & oncology : H&O 20070101 |
| An unusual cause of unilateral pleural effusion in the setting of aortic stenosis: acute myeloid leukemia. | Internal medicine (Tokyo, Japan) 20070101 |
| Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patients. | Acta haematologica 20070101 |
| Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis. | Haematologica 20070101 |
| Cutaneous Mycobacterium chelonae infection in chronic lymphocytic leukaemia. | Haematologica 20070101 |
| Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101 |
| [Anemia in chronic lymphatic leukemia: is erythropoietin the solution?]. | Revista de medicina de la Universidad de Navarra 20070101 |
| Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia. | Anticancer research 20070101 |
| Fludarabine: a review of its use in non-Hodgkin's lymphoma. | Drugs 20070101 |
| Paraneoplastic pemphigus associated with fludarabine use. | Medical oncology (Northwood, London, England) 20070101 |
| [Visual cortes--is it a concern?]. | Bulletin de la Societe belge d'ophtalmologie 20070101 |
| [Allogenic transplantation of hemopoietic stem cells in low-intensity regimes in patients with hematological malignancies]. | Terapevticheskii arkhiv 20070101 |
| [Prognostic significance of immunoglobulin variable region gene mutations in B-CLL patients treated with combination therapy fludarabine plus cyclophosphamide]. | Terapevticheskii arkhiv 20070101 |
| Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells. | Annals of clinical microbiology and antimicrobials 20070101 |
| Chronic lymphocytic leukemia masquerading as uveitis. | Retina (Philadelphia, Pa.) 20070101 |
| The effects of nucleoside analogues on promoter methylation of selected tumor suppressor genes in MCF-7 and MDA-MB-231 breast cancer cell lines. | Nucleosides, nucleotides & nucleic acids 20070101 |
| Chronic lymphocytic leukemia in the recent 10 years and treatment effects of Fludarabin. | Asian Pacific journal of cancer prevention : APJCP 20070101 |
| Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG). | Blood 20061215 |
| Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal. | Blood 20061215 |
| Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy. | Neurology 20061212 |
| Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia. | Leukemia research 20061201 |
| High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients. | American journal of hematology 20061201 |
| Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201 |
| Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201 |
| Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells. | Leukemia & lymphoma 20061201 |
| Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma. | Haematologica 20061201 |
| Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys. | Journal of controlled release : official journal of the Controlled Release Society 20061128 |
| Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus. | Antiviral research 20061101 |
| Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens. | British journal of haematology 20061101 |
| Rapid progression of metastatic osteosarcoma after initiation of a reduced-intensity conditioning regimen with immunosuppressive fludarabine. | Pediatric transplantation 20061101 |
| Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine. | European journal of haematology 20061101 |
| Treatment-related myelodysplasia following fludarabine combination chemotherapy. | Haematologica 20061101 |
| Chronic lymphocytic leukemia: current and emerging treatment approaches. | Clinical advances in hematology & oncology : H&O 20061101 |
| Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning. | Transplantation 20061015 |
| Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG). | Annals of hematology 20061001 |
| Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen. | European journal of haematology 20061001 |
| Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes. | British journal of haematology 20061001 |
| Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation. | Bone marrow transplantation 20061001 |
| Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia. | Bone marrow transplantation 20061001 |
| Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA. | Cancer research 20061001 |
| Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061001 |
| Flow cytometric evaluation of red blood cell chimerism after bone marrow transplantation in Iranian patients: a preliminary study. | Archives of Iranian medicine 20061001 |
| Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001 |
| Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001 |
| Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001 |
| [T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome]. | Zeitschrift fur Rheumatologie 20060901 |
| Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia. | Cancer 20060901 |
| Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. | Bone marrow transplantation 20060901 |
| High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication. | Annals of oncology : official journal of the European Society for Medical Oncology 20060901 |
| Role of fludarabine in hematological malignancies. | Expert review of anticancer therapy 20060901 |
| Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma. | Leukemia & lymphoma 20060901 |
| Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20060901 |
| Nelarabine: a new purine analog in the treatment of hematologic malignancies. | Reviews on recent clinical trials 20060901 |
| Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia. | Blood 20060815 |
| The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders. | Cancer 20060815 |
| Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. | Blood 20060801 |
| Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis. | Bone marrow transplantation 20060801 |
| Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine. | Journal of medical virology 20060801 |
| Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis. | Cancer treatment reviews 20060801 |
| Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning. | Bone marrow transplantation 20060801 |
| Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece. | Journal of medical microbiology 20060801 |
| A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060801 |
| Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060801 |
| Fludarabine in chronic lymphocytic leukaemia. | Expert opinion on pharmacotherapy 20060801 |
| Concomitant Epstein-Barr virus-negative large B-cell lymphoma (Richter syndrome) and Epstein-Barr virus- positive B-cell lymphoproliferation after treatment with fludarabine and cyclophosphamide in a patient with B-cell chronic lymphocytic leukemia. | Archives of pathology & laboratory medicine 20060801 |
| Affinity of corpora amylacea for oligonucleotides: sequence dependency and proteinaceous binding motif. | Neuropathology : official journal of the Japanese Society of Neuropathology 20060801 |
| MicroRNAs in leukemia. | Clinical advances in hematology & oncology : H&O 20060801 |
| Purine antagonists for chronic lymphocytic leukaemia. | The Cochrane database of systematic reviews 20060719 |
| Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation. | European journal of haematology 20060701 |
| An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20060701 |
| Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060701 |
| Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT. | Experimental hematology 20060701 |
| Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia. | British journal of haematology 20060701 |
| High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders. | British journal of haematology 20060701 |
| [Reduced-intensity cord blood transplantation for adult hematological diseases]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060701 |
| [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060701 |
| Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment. | Leukemia & lymphoma 20060701 |
| Gene expression profiles of two accelerations in a CML patient. | Leukemia research 20060601 |
| A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. | European journal of haematology 20060601 |
| Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma. | Cancer 20060601 |
| Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone. | American journal of hematology 20060601 |
| Another case of myelodysplasia with monosomy 7 following fludarabine-based chemotherapy. | American journal of hematology 20060601 |
| Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen. | British journal of haematology 20060601 |
| Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning. | Pediatric transplantation 20060601 |
| Sensitivity analysis of cost factors for various therapy options in the treatment of follicular lymphoma. | Onkologie 20060601 |
| Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide. | International journal of hematology 20060601 |
| Diagnosis of a primary testicular lymphoma by echography and magnetic resonance imaging. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060601 |
| Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors. | Hematology (Amsterdam, Netherlands) 20060601 |
| Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome. | Hematology (Amsterdam, Netherlands) 20060601 |
| Combined antiherpetic effect of complex preparation 'Viferon-eye drops' and modified nucleosides. | Bulletin of experimental biology and medicine 20060601 |
| Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060520 |
| Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. | Pediatric blood & cancer 20060501 |
| DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells. | Leukemia 20060501 |
| Fludarabine induces pro-inflammatory activation of human monocytic cells through a MAPK/ERK pathway. | International immunopharmacology 20060501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. | British journal of haematology 20060501 |
| Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor. | International journal of hematology 20060501 |
| Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning. | International journal of hematology 20060501 |
| The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative. | The Journal of biological chemistry 20060414 |
| Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter. | Gene 20060412 |
| Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells. | Journal of cellular physiology 20060401 |
| Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older. | Leukemia research 20060401 |
| Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. | Bone marrow transplantation 20060401 |
| The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia. | Haematologica 20060401 |
| Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060401 |
| Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia. | Seminars in hematology 20060401 |
| Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis. | American journal of hematology 20060401 |
| The infectious consequences of rituximab addition to fludarabine-containing regimens. | Blood 20060401 |
| [State of the art in the treatment of chronic leukemias]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060401 |
| PS exposure increases the susceptibility of cells to fusion with DOTAP liposomes. | Chemico-biological interactions 20060325 |
| AMPK regulation of mouse oocyte meiotic resumption in vitro. | Developmental biology 20060315 |
| Bilateral ear Sweet's syndrome in a case with relapse acute myeloblastic leukemia. | Leukemia research 20060301 |
| Stress stimulates AMP-activated protein kinase and meiotic resumption in mouse oocytes. | Biology of reproduction 20060301 |
| Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies. | Bone marrow transplantation 20060301 |
| Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome. | Cancer 20060301 |
| Positron emission tomography--positive distal femur following fludarabine, dexamethasone and mitoxantrone chemotherapy. | British journal of haematology 20060301 |
| Guidelines on the management of Waldenström macroglobulinaemia. | British journal of haematology 20060301 |
| Exacerbation of chronic epidural abscess following a fludarabine-based preparative regimen. | American journal of hematology 20060301 |
| Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience. | American journal of hematology 20060301 |
| Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20060301 |
| [Inhibition effect of fludarabine on the growth of myelodysplastic syndrome cell line MUTZ-1 and its mechanism]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20060301 |
| [Therapy for herpes simplex virus encephalitis]. | Nihon rinsho. Japanese journal of clinical medicine 20060301 |
| [Treatment of neonatal herpes]. | Nihon rinsho. Japanese journal of clinical medicine 20060301 |
| F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation. | Nucleosides, nucleotides & nucleic acids 20060301 |
| Advances in the treatment of chronic lymphocytic leukemia. | Current hematologic malignancy reports 20060301 |
| Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. | Blood 20060201 |
| Modulation of sFas indicates apoptosis in human herpes simplex encephalitis. | Journal of neuroimmunology 20060201 |
| Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML. | Bone marrow transplantation 20060201 |
| Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer. | Bone marrow transplantation 20060201 |
| Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion. | European journal of haematology 20060201 |
| Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS). | Bone marrow transplantation 20060201 |
| Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab. | Clinical and laboratory haematology 20060201 |
| Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060201 |
| Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia. | Apoptosis : an international journal on programmed cell death 20060201 |
| [Effect of inhibitors of signal transducer and activator of transcription-1/3 on expression of tumor necrosis factor-alpha induced by high mobility group box-1 protein inflammatory response in rat peritoneal macrophages]. | Zhonghua wai ke za zhi [Chinese journal of surgery] 20060201 |
| Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120 |
| A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens. | Cancer 20060115 |
| Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL. | Blood 20060101 |
| Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2. | Drug metabolism and disposition: the biological fate of chemicals 20060101 |
| A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems. | Molecular pharmacology 20060101 |
| Another case of PORN (bilateral progressive outer retinal necrosis) after allogeneic stem cell transplantation. | Bone marrow transplantation 20060101 |
| Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases. | Annals of hematology 20060101 |
| Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan. | Leukemia & lymphoma 20060101 |
| Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study. | European journal of haematology 20060101 |
| A pull-down assay for 5' AMP-activated protein kinase activity using the GST-fused protein. | Molecular biotechnology 20060101 |
| The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060101 |
| Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience. | Japanese journal of clinical oncology 20060101 |
| Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study. | Acta haematologica 20060101 |
| Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. | International journal of hematology 20060101 |
| Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia. | JPMA. The Journal of the Pakistan Medical Association 20060101 |
| [Allogeneic stem cell transplantation with fludarabine/melphalan (non-TBI and non-BU/CY) for patients aged 50 or more]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060101 |
| Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101 |
| [Fever and dyspnea in a patient with chronic lymphatic leukemia under treatment with fludarabine]. | Enfermedades infecciosas y microbiologia clinica 20060101 |
| In vitro comparison of antiviral drugs against feline herpesvirus 1. | BMC veterinary research 20060101 |
| Skin involvement in Hodgkin's disease. | Cancer investigation 20060101 |
| Preparation of a fludarabine intermediate via selective alkylation of 2-fluoroadenine. | Nucleosides, nucleotides & nucleic acids 20060101 |
| [Remission in T-cell prolymphocytic leukemia during the FMC treatment course]. | Terapevticheskii arkhiv 20060101 |
| IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience. | American journal of therapeutics 20060101 |
| High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission. | Medical oncology (Northwood, London, England) 20060101 |
| Alteration of DNA methylation status in K562 and MCF-7 cancer cell lines by nucleoside analogues. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia. | Cancer 20051215 |
| OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action. | Journal of the National Cancer Institute 20051207 |
| Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. | Journal of hepatology 20051201 |
| Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma. | Bone marrow transplantation 20051201 |
| Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. | Bone marrow transplantation 20051201 |
| Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. | Leukemia & lymphoma 20051201 |
| Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. | European journal of haematology 20051201 |
| Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen. | Clinical transplantation 20051201 |
| Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051201 |
| Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation. | Haematologica 20051201 |
| Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. | Haematologica 20051201 |
| [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma]. | Ai zheng = Aizheng = Chinese journal of cancer 20051201 |
| Significance of VH genes mutation status for prognosis of CLL patients. | Experimental oncology 20051201 |
| Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL). | Blood 20051115 |
| An irradiation-free nonmyeloablative bone marrow transplantation model: importance of the balance between donor T-cell number and the intensity of conditioning. | Transplantation 20051115 |
| Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. | Blood 20051101 |
| FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia. | Annals of hematology 20051101 |
| Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706. | Leukemia 20051101 |
| Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia. | Leukemia & lymphoma 20051101 |
| Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. | Haematologica 20051101 |
| Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma. | Clinical lymphoma & myeloma 20051101 |
| [Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia]. | Fukuoka igaku zasshi = Hukuoka acta medica 20051101 |
| Richter's syndrome--the downside of fludarabine? | Leukemia research 20051001 |
| Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia. | Leukemia research 20051001 |
| Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients. | Leukemia 20051001 |
| Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review). | International journal of oncology 20051001 |
| Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001 |
| Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine. | Japanese journal of clinical oncology 20051001 |
| Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation. | British journal of haematology 20051001 |
| High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML. | Therapeutic drug monitoring 20051001 |
| Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20051001 |
| Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. | British journal of haematology 20051001 |
| Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051001 |
| [Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine]. | Deutsche medizinische Wochenschrift (1946) 20050923 |
| Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. | Blood 20050915 |
| Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. | Blood 20050901 |
| Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation. | Leukemia & lymphoma 20050901 |
| 'Specific' cutaneous infiltrate of B-cell chronic lymphocytic leukemia at the site of a florid herpes simplex infection. | Journal of cutaneous pathology 20050901 |
| Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. | British journal of haematology 20050901 |
| Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. | Medicine 20050901 |
| Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20050901 |
| [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia]. | Orvosi hetilap 20050821 |
| Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| [Treatment of refractory and relapsed acute lymphocytic leukemia in adults]. | Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20050818 |
| Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids. | American journal of physiology. Renal physiology 20050801 |
| Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. | Bone marrow transplantation 20050801 |
| Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia. | American journal of hematology 20050801 |
| 188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study. | British journal of haematology 20050801 |
| Rational design of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors: predicting enzyme conformational change and metabolism. | Journal of medicinal chemistry 20050728 |
| The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. | Blood 20050715 |
| Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen. | Cancer 20050715 |
| Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment. | Annals of hematology 20050701 |
| An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation. | Japanese journal of clinical oncology 20050701 |
| Extrapulmonary tuberculous abscess in chronic lymphocytic leukaemia (CLL) treated with fludarabine: case report and review of literature. | American journal of hematology 20050701 |
| Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050701 |
| Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia. | Leukemia & lymphoma 20050701 |
| Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia. | Leukemia & lymphoma 20050701 |
| Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation. | British journal of haematology 20050701 |
| A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050625 |
| Changing the way we think about chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620 |
| Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620 |
| Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620 |
| Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. | Blood 20050615 |
| Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway. | Biochemical and biophysical research communications 20050603 |
| Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. | Blood 20050601 |
| Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML. | Leukemia 20050601 |
| Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601 |
| CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors. | Bone marrow transplantation 20050601 |
| Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. | European journal of haematology 20050601 |
| Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia. | Cancer treatment reviews 20050601 |
| Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. | British journal of haematology 20050601 |
| Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050601 |
| Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050601 |
| An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment. | Clinical and laboratory haematology 20050601 |
| Pulmonary lymphoma of the mucosa-associated lymphoid tissue type: Report of a case with cytological, histological, immunophenotypical correlation, and review of the literature. | Annals of diagnostic pathology 20050601 |
| Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia. | Haematologica 20050601 |
| Economic assessment on the management of chronic lymphocytic leukaemia. | Expert opinion on pharmacotherapy 20050601 |
| [Effects of FLAG regimen in treatment of refractory or relapsed acute myeloid leukemia]. | Zhongguo shi yan xue ye xue za zhi 20050601 |
| The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma. | Clinical lymphoma 20050601 |
| FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study. | JPMA. The Journal of the Pakistan Medical Association 20050601 |
| Apoptosis of peripheral human blood lymphocytes induced by physical-chemical influences and generation of reactive oxygen species. | Annals of the New York Academy of Sciences 20050601 |
| Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues. | International journal of hematology 20050601 |
| Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. | Purinergic signalling 20050601 |
| Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity. | European journal of pharmacology 20050509 |
| Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality. | Annals of hematology 20050501 |
| Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. | Bone marrow transplantation 20050501 |
| Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity. | Bone marrow transplantation 20050501 |
| Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy. | Haematologica 20050501 |
| Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies. | Haematologica 20050501 |
| [Herpes simplex encephalitis originating from bilateral thalamic lesions with hemorrhagic component]. | Rinsho shinkeigaku = Clinical neurology 20050501 |
| Successful treatment of lymphoma with fludarabine combined with rituximab after immune thrombocytopenia induced by fludarabine. | Annals of hematology 20050401 |
| Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. | Leukemia research 20050401 |
| Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. | Bone marrow transplantation 20050401 |
| Multiple bilateral parotid sialoliths in a patient with mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) of the salivary glands. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20050401 |
| Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia. | European journal of haematology 20050401 |
| Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF. | Bone marrow transplantation 20050401 |
| Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401 |
| p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV. | British journal of haematology 20050401 |
| Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine. | British journal of haematology 20050401 |
| Five-month marrow aplasia in a child with refractory acute myeloid leukemia: successful management with continuous granulocyte support and reduced-intensity conditioning followed by matched unrelated bone marrow transplantation. | Journal of pediatric hematology/oncology 20050401 |
| Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin. | Stem cells and development 20050401 |
| Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP. | Leukemia & lymphoma 20050401 |
| Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050320 |
| Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. | Blood 20050315 |
| Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB. | The Journal of biological chemistry 20050311 |
| Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. | Blood 20050301 |
| Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20050301 |
| Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. | Bone marrow transplantation 20050301 |
| Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia. | Bone marrow transplantation 20050301 |
| Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin? | Annals of oncology : official journal of the European Society for Medical Oncology 20050301 |
| Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies. | Annals of oncology : official journal of the European Society for Medical Oncology 20050301 |
| Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis. | British journal of haematology 20050301 |
| Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20050301 |
| Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation. | Bone marrow transplantation 20050301 |
| [Current and new therapeutic strategies in acute myeloid leukemia]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050301 |
| Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders. | Clinical lymphoma 20050301 |
| [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues]. | Bulletin du cancer 20050301 |
| [News in therapeutic management of chronic lymphoid leukemia]. | Bulletin du cancer 20050301 |
| High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia. | International journal of cancer 20050220 |
| Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler). | Bone marrow transplantation 20050201 |
| Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor. | Pediatric transplantation 20050201 |
| Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201 |
| The role of mitoxantrone in the treatment of indolent lymphomas. | The oncologist 20050201 |
| Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia. | Haematologica 20050201 |
| Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis. | Haematologica 20050201 |
| Peripheral blood stem cell mobilization and harvesting after fludarabine therapy for low-grade lymphoma and chronic lymphocytic leukemia. | Stem cells and development 20050201 |
| Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201 |
| Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence. | Prescrire international 20050201 |
| Lymphoma: diagnosis, staging, natural history, and treatment strategies. | Seminars in oncology 20050201 |
| Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations. | Blood 20050115 |
| Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. | Blood 20050101 |
| Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells. | Leukemia 20050101 |
| Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. | Bone marrow transplantation 20050101 |
| Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus. | Antiviral research 20050101 |
| Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine. | Haematologica 20050101 |
| PNP with Waldenström's macroglobulinaemia. | Clinical and experimental dermatology 20050101 |
| Neonatal herpes: what have we learned. | Seminars in pediatric infectious diseases 20050101 |
| Fludarabine-based conditioning used in successful bone marrow transplantation from an unrelated donor in a heavily transfused patient with severe aplastic anemia. | International journal of hematology 20050101 |
| Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). | The pharmacogenomics journal 20050101 |
| In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses. | Neoplasma 20050101 |
| Analysis of 1H NMR-detectable mobile lipid domains for assessment of apoptosis induced by inhibitors of DNA synthesis and replication. | Cell biology international 20050101 |
| Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link? | Anticancer research 20050101 |
| Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience. | Neoplasma 20050101 |
| [Antiherpetic therapy]. | Oftalmologia (Bucharest, Romania : 1990) 20050101 |
| Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice. | Antiviral chemistry & chemotherapy 20050101 |
| Novel dinucleoside 5',5'-triphosphate cap analogues. Synthesis and affinity for murine translation factor eIF4E. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20050101 |
| Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. | Annals of the New York Academy of Sciences 20050101 |
| Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL. | Roczniki Akademii Medycznej w Bialymstoku (1995) 20050101 |
| [Progress and perspectives in the treatment of systemic lupus erythematosus]. | Przeglad lekarski 20050101 |
| [Mantle cell lymphoma mimicking chronic lymphocytic leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20050101 |
| Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway. | Oncogene 20041216 |
| Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. | Blood 20041201 |
| Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. | Leukemia 20041201 |
| Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. | Bone marrow transplantation 20041201 |
| Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease. | Bone marrow transplantation 20041201 |
| Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies. | Bone marrow transplantation 20041201 |
| VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia. | European journal of haematology 20041201 |
| The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro. | European journal of haematology 20041201 |
| The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia. | International journal of oncology 20041201 |
| Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041201 |
| Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia. | Haematologica 20041201 |
| Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma. | Haematologica 20041201 |
| A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity. | Haematologica 20041201 |
| Effect of fludarabine on leukocyte functions. | Chemotherapy 20041201 |
| Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion. | Cell cycle (Georgetown, Tex.) 20041201 |
| Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia. | Leukemia & lymphoma 20041201 |
| Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia. | Saudi medical journal 20041201 |
| Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes. | Oncogene 20041125 |
| The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. | Blood 20041115 |
| Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. | Annals of hematology 20041101 |
| A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies. | Cancer 20041101 |
| Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update. | Leukemia 20041101 |
| Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes. | Biochemical pharmacology 20041101 |
| Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion. | British journal of haematology 20041101 |
| Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20041101 |
| Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: a systematic review and meta-analysis. | Leukemia & lymphoma 20041101 |
| Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect. | Leukemia & lymphoma 20041101 |
| Conditioning regimen of melphalan, fludarabine and total body irradiation in unmanipulated HLA haploidentical stem cell transplantation based on feto-maternal tolerance. | Internal medicine (Tokyo, Japan) 20041101 |
| The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia. | Folia morphologica 20041101 |
| Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. | Blood 20041015 |
| Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. | Blood 20041015 |
| Synthesis and antiviral activities of 1'-carbon-substituted 4'-thiothymidines. | Bioorganic & medicinal chemistry 20041015 |
| A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041015 |
| Commentary: Ch'ien LT, Cannon NJ, Charamella LJ, et al. effect of adenine arabinoside on severe herpesvirus hominis infections in man: preliminary report. J Infect Dis 1973; 128:658-63. | The Journal of infectious diseases 20041001 |
| Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma. | European journal of haematology 20041001 |
| Association between ocular herpes simplex virus and topical ocular hypotensive therapy. | Journal of glaucoma 20041001 |
| Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia. | Leukemia & lymphoma 20041001 |
| Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature. | Leukemia & lymphoma 20041001 |
| Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20041001 |
| Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. 1973. | The Journal of infectious diseases 20041001 |
| Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. | British journal of haematology 20041001 |
| Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041001 |
| [Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study]. | Zhongguo shi yan xue ye xue za zhi 20041001 |
| [Analysis of varicella zoster virus infection following allogeneic stem cell transplants]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20041001 |
| Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. | Blood 20040915 |
| The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill. | Cancer research 20040915 |
| Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. | Blood 20040901 |
| Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma. | Leukemia & lymphoma 20040901 |
| Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO). | Leukemia & lymphoma 20040901 |
| BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning. | Leukemia 20040901 |
| The role of fludarabine in the treatment of follicular and mantle cell lymphoma. | Cancer 20040901 |
| Herpes simplex virus keratitis in children. | American journal of ophthalmology 20040901 |
| Therapeutic basis of vidarabine on adenovirus-induced haemorrhagic cystitis. | Antiviral chemistry & chemotherapy 20040901 |
| [New perspectives in the evolution of prognosis and treatment of chronic lymphocytic leukaemia]. | Orvosi hetilap 20040829 |
| Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI). | British journal of cancer 20040816 |
| Reversible paraneoplastic neuropathy associated with T-cell large granular lymphocyte leukemia. | Neurology 20040810 |
| Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. | Blood 20040801 |
| Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors. | Bone marrow transplantation 20040801 |
| Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies. | European journal of haematology 20040801 |
| Treatment of adenovirus infections in the immunocompromised host. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20040801 |
| Histone deacetylase inhibitor enhances the anti-leukemic activity of an established nucleoside analogue. | Cancer biology & therapy 20040801 |
| Fatal peripheral neuropathy following FLA chemotherapy. | Clinical and laboratory haematology 20040801 |
| Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia. | British journal of haematology 20040801 |
| Cytopenia and hematopoietic recovery after low intensity conditioning transplants. | Croatian medical journal 20040801 |
| [The expression of HBsAg and HBcAg in the liver tissues of the patients with chronic hepatitis B before and after the treatment with arabinosyladenine]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20040801 |
| Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. | Arthritis and rheumatism 20040801 |
| The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine. | Leukemia 20040701 |
| Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation. | Bone marrow transplantation 20040701 |
| Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin. | Leukemia research 20040701 |
| Acute renal failure after nonmyeloablative hematopoietic cell transplantation. | Journal of the American Society of Nephrology : JASN 20040701 |
| 9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells. | Molecular pharmacology 20040701 |
| Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. | Bone marrow transplantation 20040701 |
| Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients. | Bone marrow transplantation 20040701 |
| Guillain-Barré syndrome complicating mobilization therapy in a case of B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20040701 |
| Advances in the diagnosis and treatment of chronic lymphocytic leukemia. | Clinical advances in hematology & oncology : H&O 20040701 |
| Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia. | Cancer 20040615 |
| Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. | Bone marrow transplantation 20040601 |
| Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection. | Blood 20040601 |
| Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040601 |
| Characterization of glycine N-methyltransferase from rabbit liver. | Biochemistry and cell biology = Biochimie et biologie cellulaire 20040601 |
| Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen. | Haematologica 20040601 |
| A case of varicella-associated idiopathic thrombocytopenic purpura in adulthood. | The Journal of dermatology 20040601 |
| Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group. | Leukemia & lymphoma 20040601 |
| Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre study. | Leukemia & lymphoma 20040601 |
| High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients. | The Korean journal of internal medicine 20040601 |
| Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors. | Journal of medicinal chemistry 20040520 |
| Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction. | The Biochemical journal 20040515 |
| Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies. | Cancer 20040515 |
| Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. | Cancer 20040515 |
| Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions. | Blood 20040501 |
| Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine. | Leukemia 20040501 |
| Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies. | Bone marrow transplantation 20040501 |
| High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma. | Bone marrow transplantation 20040501 |
| Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era. | Leukemia research 20040501 |
| Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium. | Leukemia research 20040501 |
| Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans. | Journal of the European Academy of Dermatology and Venereology : JEADV 20040501 |
| Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. | The American journal of surgical pathology 20040501 |
| Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma. | Leukemia & lymphoma 20040501 |
| Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver. | Journal of the American Chemical Society 20040428 |
| Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. | Journal of medicinal chemistry 20040422 |
| The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients. | Blood 20040415 |
| Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease. | Annals of hematology 20040401 |
| Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor. | Bone marrow transplantation 20040401 |
| Aspergillus fumigatus: a rare cause of vertebral osteomyelitis. | Haematologica 20040401 |
| [Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases]. | Ai zheng = Aizheng = Chinese journal of cancer 20040401 |
| Transient absence of hepatic uptake on gallium-67 scintigraphy following fludarabine therapy. | Clinical nuclear medicine 20040401 |
| Sensitivity of B-cell chronic lymphocytic leukemia to Rituximab and Campath-1H and correlation with the expression of cell cycle regulatory proteins. | Croatian medical journal 20040401 |
| A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia. | Leukemia research 20040401 |
| Treatment of chronic lymphocytic leukemia. | Seminars in oncology 20040401 |
| Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia. | International journal of hematology 20040401 |
| [Waldenstrom macroglobulinemia]. | Praxis 20040331 |
| Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. | Blood 20040301 |
| Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis. | Bone marrow transplantation 20040301 |
| Reversible acute renal failure following single administration of fludarabine. | Bone marrow transplantation 20040301 |
| Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients. | British journal of haematology 20040301 |
| Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040301 |
| [Reduced intensity stem cell transplantation for metastatic renal cell carcinoma]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20040301 |
| Synthesis of 2',5'-dideoxy-2-fluoroadenosine and 2',5'-dideoxy-2,5'-difluoroadenosine: potent P-site inhibitors of adenylyl cyclase. | Journal of medicinal chemistry 20040226 |
| Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo. | Leukemia research 20040201 |
| Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors. | British journal of pharmacology 20040201 |
| Nonmyeloablative stem cell transplantation for lymphoma. | Seminars in oncology 20040201 |
| [Drug-resistant B cell chronic lymphocytic leukemia safely treated with rituximab to control leukemic cell increment and platelet transfusion dependence]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040201 |
| Advancing therapy for chronic lymphocytic leukemia--the role of rituximab. | Seminars in oncology 20040201 |
| High dose chlorambucil in the treatment of lymphoid malignancies. | Leukemia & lymphoma 20040201 |
| Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. | Blood 20040115 |
| Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. | Blood 20040115 |
| Simple and sensitive method for quantification of fludarabine triphosphate intracellular concentration in leukemic cells using isocratic liquid chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040105 |
| Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. | Blood 20040101 |
| Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions. | Leukemia 20040101 |
| Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H. | Leukemia 20040101 |
| Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. | British journal of haematology 20040101 |
| Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells. | British journal of haematology 20040101 |
| Treatment options for newly diagnosed patients with chronic lymphocytic leukemia. | Current hematology reports 20040101 |
| Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Fludarabine-induced hemolytic anemia: successful treatment by rituximab. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report. | Gynecologic oncology 20040101 |
| Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040101 |
| Ida-FLAG plus imatinib mesylate-induced molecular remission in a patient with chemoresistant Ph1+ acute myeloid leukemia. | European journal of haematology 20040101 |
| Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection. | International journal of hematology 20040101 |
| Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides. | Nucleosides, nucleotides & nucleic acids 20040101 |
| Repeated rituximab maintenance courses in fludarabine-failed young patients with chronic lymphocytic leukaemia responding to FAND chemotherapy. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II study. | Leukemia & lymphoma 20040101 |
| Fludarabine in chronic lymphocytic leukemia and other hematological malignancies: progress in treatment. Fludarabine supplement. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Chemotherapy combination treatment regimens with fludarabine in chronic lymphocytic leukemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Oral fludarabine therapy in chronic lymphocytic leukemia--increased convenience. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Use of fludarabine in the treatment of acute myeloid leukemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Future prospects for fludarabine-containing regimens in the treatment of hematological cancers. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Collisionally-induced dissociation of purine antiviral agents: mechanisms of ion formation using gas phase hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry. | European journal of mass spectrometry (Chichester, England) 20040101 |
| Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation. | Annals of hematology 20040101 |
| Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia. | The Annals of pharmacotherapy 20040101 |
| Fludarabine combination regimen severely affected peripheral blood stem cell mobilization. | Acta haematologica 20040101 |
| A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Fludarabine as the possible cause of acute myelofibrosis. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Reconstructing immunity after allogeneic transplantation. | Immunologic research 20040101 |
| Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H). | Journal of immunotherapy (Hagerstown, Md. : 1997) 20040101 |
| Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Purine analogs in leukemia. | Advances in pharmacology (San Diego, Calif.) 20040101 |
| Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| [Evaluation of the clinical effectivity and toxicity of the FDN regimen (fludarabin, mitoxantron, dexamethason) in patients with follicular lymphoma]. | Casopis lekaru ceskych 20040101 |
| [Biotechnological synthesis of ribavirin. Effect of ribavirin and its various combinations on the reproduction of Vaccinia virus]. | Bioorganicheskaia khimiia 20040101 |
| Effects of fludarabine treatment on murine lupus nephritis. | Lupus 20040101 |
| [Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy]. | Voprosy onkologii 20040101 |
| A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia. | Blood 20031215 |
| Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia. | Cancer chemotherapy and pharmacology 20031201 |
| In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine. | Biochemical pharmacology 20031201 |
| Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies. | Clinical and laboratory haematology 20031201 |
| Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. | Transfusion 20031201 |
| Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement. | International journal of clinical oncology 20031201 |
| Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. | Haematologica 20031201 |
| [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia]. | Ai zheng = Aizheng = Chinese journal of cancer 20031201 |
| B-cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen. | Transplantation proceedings 20031201 |
| [Hairy cell leukemia: report on one case with survival for 10 years]. | Zhongguo shi yan xue ye xue za zhi 20031201 |
| 45th annual meeting of the American Society of Hematology. December 6-9, 2003, San Diego, California. | Clinical lymphoma 20031201 |
| Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine. | Leukemia & lymphoma 20031201 |
| [Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands]. | Nederlands tijdschrift voor geneeskunde 20031122 |
| Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine. | Biochemical and biophysical research communications 20031121 |
| Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. | Blood 20031115 |
| Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia. | Oncogene 20031113 |
| Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. | Journal of leukocyte biology 20031101 |
| The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. | Bone marrow transplantation 20031101 |
| Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects. | Annals of the rheumatic diseases 20031101 |
| Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. | Haematologica 20031101 |
| Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation. | British journal of haematology 20031101 |
| Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia. | Leukemia & lymphoma 20031101 |
| Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia. | Leukemia research 20031001 |
| Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease. | Histology and histopathology 20031001 |
| Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. | Bone marrow transplantation 20031001 |
| The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia. | British journal of haematology 20031001 |
| Fludarabine-related myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001 |
| Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin. | Leukemia 20031001 |
| Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome. | Journal of pediatric hematology/oncology 20031001 |
| Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases. | Experimental hematology 20031001 |
| Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031001 |
| [Modified FLAG regimen in the management of refractory acute myeloid leukemia]. | Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031001 |
| Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031001 |
| Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. | The Pediatric infectious disease journal 20031001 |
| Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. | Leukemia & lymphoma 20031001 |
| Fatal fludarabine-induced extensive bone marrow necrosis in a patient with chronic lymphocytic leukemia. | Leukemia & lymphoma 20031001 |
| Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia. | JPMA. The Journal of the Pakistan Medical Association 20031001 |
| [Pressure pain in the left epigastrium: blood picture provides diagnosis. Chronic lymphatic leukemia]. | MMW Fortschritte der Medizin 20030925 |
| HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. | Blood 20030915 |
| Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia. | Blood 20030915 |
| Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. | Blood 20030901 |
| Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia. | Cancer chemotherapy and pharmacology 20030901 |
| Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity. | Annals of hematology 20030901 |
| Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies. | Bone marrow transplantation 20030901 |
| A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. | Bone marrow transplantation 20030901 |
| FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia. | Bone marrow transplantation 20030901 |
| A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030901 |
| [Non-myeloablative or reduced intensity stem cell transplantation preparative regimens]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Mini-transplantation from HLA-mismatched donors]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Mini-transplantation from cord blood]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Reduced-intensity stem cell transplantation (RIST) for lymphoproliferative diseases]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Non-myeloablative stem cell transplantation for non-malignant hematologic disorders]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Gastrointestinal cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Nonmyeloablative allogeneic peripheral blood stem cell transplantation of renal cell carcinoma]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro. | Leukemia & lymphoma 20030901 |
| Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells. | Blood 20030801 |
| Bilateral optic disc swelling as the presenting sign of Waldenström's macroglobulinaemia. | Acta ophthalmologica Scandinavica 20030801 |
| Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria. | European journal of haematology 20030801 |
| A novel t(15;17) translocation in acute myeloid leukaemia not associated with PML/RARalpha rearrangement. | Clinical and laboratory haematology 20030801 |
| Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness. | Bone marrow transplantation 20030801 |
| Activation of a p53-mediated apoptotic pathway in quiescent lymphocytes after the inhibition of DNA repair by fludarabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030801 |
| Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030801 |
| Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. | Haematologica 20030801 |
| Early reappearance of primary solid cancer in patients treated with purine analogs. | Journal of chemotherapy (Florence, Italy) 20030801 |
| [Seventeen cases of nonmyeloablative stem cell transplantation using a conditioning regimen containing fludarabine]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801 |
| [Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801 |
| Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. | Blood 20030715 |
| Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. | Blood 20030715 |
| Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715 |
| [Current concepts in chronic lymphocytic leukemia. Better chances for young patients]. | MMW Fortschritte der Medizin 20030710 |
| Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia. | European journal of haematology 20030701 |
| Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies. | Bone marrow transplantation 20030701 |
| Human herpesvirus 6 encephalitis following flag chemotherapy. | British journal of haematology 20030701 |
| Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030701 |
| Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030701 |
| Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030701 |
| Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma. | Leukemia & lymphoma 20030701 |
| Effects of etoposide and fludarabine in subtoxic doses on karyotype of human malignant lymphoid Namalwa cells. | Bulletin of experimental biology and medicine 20030701 |
| Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia. | The Journal of the Association of Physicians of India 20030701 |
| [Evidence-based therapy for chronic leukemia]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20030610 |
| Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. | Annals of hematology 20030601 |
| Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience. | Hematology (Amsterdam, Netherlands) 20030601 |
| Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study. | European journal of haematology 20030601 |
| Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases. | Leukemia 20030601 |
| Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia. | Bone marrow transplantation 20030601 |
| Mechanism of action of purine analogues in chronic lymphocytic leukaemia. | British journal of haematology 20030601 |
| Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. | British journal of haematology 20030601 |
| Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide. | Leukemia & lymphoma 20030601 |
| [The therapeutic effects of FLAG regime for refractory and relapsing acute leukemia]. | Zhonghua nei ke za zhi 20030601 |
| Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030515 |
| Smallpox and smallpox vaccination. | The New England journal of medicine 20030508 |
| Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire? | Leukemia research 20030501 |
| Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine. | The Annals of pharmacotherapy 20030501 |
| Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. | Bone marrow transplantation 20030501 |
| Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation. | Bone marrow transplantation 20030501 |
| Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning. | Leukemia 20030501 |
| Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. | Leukemia 20030501 |
| Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030415 |
| Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia. | Cancer 20030401 |
| Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030401 |
| Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review. | American journal of hematology 20030401 |
| [Acyclovir-resistant herpes exulcerans et persistens. Type II]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20030401 |
| Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. | Haematologica 20030401 |
| Bilateral orbital masses in a patient with B-cell chronic lymph. | Haematologica 20030401 |
| Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies. | British journal of haematology 20030401 |
| FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. | Annals of hematology 20030401 |
| Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine. | Annals of hematology 20030401 |
| Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy. | Cell death and differentiation 20030401 |
| Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003). | Seminars in oncology 20030401 |
| Fludarabine in Waldenstrom's macroglobulinemia. | Seminars in oncology 20030401 |
| Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030401 |
| Management of acyclovir-resistant herpes simplex virus. | Dermatologic clinics 20030401 |
| Non-myeloablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment. | Leukemia & lymphoma 20030401 |
| Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy. | Leukemia & lymphoma 20030401 |
| Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. | Blood 20030315 |
| Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes. | Statistics in medicine 20030315 |
| Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes. | Cancer 20030315 |
| Increased CMV infection following nonmyeloablative allogeneic stem cell transplantation: a search for the guilty. | Blood 20030301 |
| Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature. | American journal of hematology 20030301 |
| Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC). | Haematologica 20030301 |
| Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301 |
| Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation. | Bone marrow transplantation 20030301 |
| Purine nucleoside analogues in the treatment of myleoid leukemias. | Leukemia & lymphoma 20030301 |
| Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia. | Leukemia & lymphoma 20030301 |
| Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs. | Leukemia & lymphoma 20030301 |
| Trisomy 15 as the sole abnormality in myelodysplastic syndromes: case report and review of the literature. | Leukemia & lymphoma 20030301 |
| Possibility of preventive treatment for EBV-associated NK cell-lineage proliferative disorders. | Internal medicine (Tokyo, Japan) 20030301 |
| Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. | Blood 20030215 |
| Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents. | Journal of virology 20030201 |
| Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis. | American journal of hematology 20030201 |
| Novel agents and strategies to treat herpes simplex virus infections. | Expert opinion on investigational drugs 20030201 |
| Advances in the treatment of hairy-cell leukaemia. | The Lancet. Oncology 20030201 |
| Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030201 |
| Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity. | British journal of haematology 20030201 |
| The relevance of nonmyeloablative transplants in developing countries: lessons from the UK experience. | Transplantation proceedings 20030201 |
| A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. | Leukemia 20030201 |
| CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation. | Haematologica 20030201 |
| Immune thrombocytopenia induced by fludarabine successfully treated with rituximab. | Haematologica 20030201 |
| Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. | Bone marrow transplantation 20030201 |
| Rituximab plus chemotherapy in follicular and mantle cell lymphomas. | Seminars in oncology 20030201 |
| Rituximab in chronic lymphocytic leukemia. | Seminars in oncology 20030201 |
| Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine. | Leukemia & lymphoma 20030201 |
| [Anti-herpetic chemotherapeutic drugs]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia. | Blood 20030115 |
| Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. | Blood 20030115 |
| The effects of cladribine and fludarabine on DNA methylation in K562 cells. | Biochemical pharmacology 20030115 |
| Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance. | Biochemical pharmacology 20030115 |
| Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). | Blood 20030101 |
| Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission. | British journal of haematology 20030101 |
| In vitro activity of potential anti-poxvirus agents. | Antiviral research 20030101 |
| Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia. | Bone marrow transplantation 20030101 |
| Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. | Acta haematologica 20030101 |
| Costs of drug delivery for CHOP, COP/CVP, and fludarabine: an international assessment. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20030101 |
| Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma. | Medical oncology (Northwood, London, England) 20030101 |
| The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro. | Archivum immunologiae et therapiae experimentalis 20030101 |
| [Long-term results of treatment of chronic B-cell lymphoid leukocytes in persons who participated in the elimination of the effects of the nuclear accident at the Chernobyl nuclear station]. | Likars'ka sprava 20030101 |
| Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma. | Urologic oncology 20030101 |
| Retreatment with rituximab alone induces sustained remission in a patient with follicular lymphoma with multiple extranodal sites of involvement, relapsing soon after primary treatment with fludarabine-rituximab. | The hematology journal : the official journal of the European Haematology Association 20030101 |
| Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions. | Oncology reports 20030101 |
| Interventions for herpes simplex virus epithelial keratitis. | The Cochrane database of systematic reviews 20030101 |
| Oral fludarabine. | Drugs 20030101 |
| Oral fludarabine: a viewpoint by Dieter Huhn. | Drugs 20030101 |
| Oral fludarabine: a viewpoint by David Oscier. | Drugs 20030101 |
| Oral fludarabine: a viewpoint by Bruce D. Cheson. | Drugs 20030101 |
| [Cytogenetic changes in the Namalwa cell line of human malignant lymphoma induced by inhibitors of DNA replication and synthesis]. | TSitologiia i genetika 20030101 |
| Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia. | Neoplasma 20030101 |
| Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. | Blood 20021215 |
| Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma. | Blood 20021215 |
| Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. | Blood 20021215 |
| Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215 |
| Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality. | Blood 20021201 |
| Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia. | British journal of haematology 20021201 |
| Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia. | British journal of haematology 20021201 |
| Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning? | Bone marrow transplantation 20021201 |
| Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma. | Bone marrow transplantation 20021201 |
| Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. | Bone marrow transplantation 20021201 |
| Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma. | Clinical lymphoma 20021201 |
| Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. | Haematologica 20021201 |
| Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. | Journal of experimental & clinical cancer research : CR 20021201 |
| Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs. | Antiviral research 20021101 |
| The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. | Blood 20021101 |
| Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia. | Blood 20021101 |
| Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. | Blood 20021101 |
| Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen. | British journal of haematology 20021101 |
| Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine. | Haematologica 20021101 |
| Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience. | Bone marrow transplantation 20021101 |
| [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia]. | Revue neurologique 20021101 |
| [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20021101 |
| [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group]. | Deutsche medizinische Wochenschrift (1946) 20021025 |
| Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels. | Virology 20021025 |
| The triterpenoid CDDO induces apoptosis in refractory CLL B cells. | Blood 20021015 |
| CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence? | American journal of hematology 20021001 |
| Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications. | Clinical and laboratory haematology 20021001 |
| Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. | British journal of haematology 20021001 |
| Chronic lymphocytic leukaemia: only treat when symptomatic. | Prescrire international 20021001 |
| The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas. | Anti-cancer drugs 20021001 |
| Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. | Blood 20020915 |
| Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia. | Blood 20020915 |
| Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915 |
| Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915 |
| Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. | Blood 20020901 |
| Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine. | Molecular pharmacology 20020901 |
| Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study. | Leukemia 20020901 |
| Fludarabine treatment of cryoglobulinemic glomerulonephritis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20020901 |
| Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients. | Haematologica 20020901 |
| Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis. | American journal of hematology 20020901 |
| Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. | Chest 20020901 |
| Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin. | Bone marrow transplantation 20020901 |
| Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma. | Bone marrow transplantation 20020901 |
| Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma. | Annals of hematology 20020901 |
| Severe hypoglycemia in a patient with acute renal failure due to tumor lysis syndrome. | The Israel Medical Association journal : IMAJ 20020901 |
| [Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine]. | Polskie Archiwum Medycyny Wewnetrznej 20020901 |
| Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. | Leukemia & lymphoma 20020901 |
| Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation. | Leukemia & lymphoma 20020901 |
| Specificity of human and rat orthologs of the concentrative nucleoside transporter, SPNT. | American journal of physiology. Renal physiology 20020801 |
| Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives. | Seminars in oncology 20020801 |
| Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs. | Cancer chemotherapy and pharmacology 20020801 |
| FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies. | Leukemia research 20020801 |
| Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants. | Journal of hematotherapy & stem cell research 20020801 |
| Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas. | Bone marrow transplantation 20020801 |
| Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes. | European journal of haematology 20020801 |
| Waldenström's macroglobulinemia: a review of therapy. | Leukemia & lymphoma 20020801 |
| Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome. | Leukemia & lymphoma 20020801 |
| Haploidentical stem cell transplantation for acute leukemia. | International journal of hematology 20020801 |
| Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases. | International journal of hematology 20020801 |
| [Clinical pharmacology of nucleoside analogues]. | Bulletin du cancer 20020801 |
| Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells. | Oncogene 20020704 |
| Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. | Blood 20020701 |
| Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine. | Haematologica 20020701 |
| Progressive multifocal leukoencephalopathy shortly after the diagnosis of follicular lymphoma in a patient treated with fludarabine. | Haematologica 20020701 |
| Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning. | British journal of haematology 20020701 |
| Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study. | Cancer chemotherapy and pharmacology 20020701 |
| Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas. | American journal of hematology 20020701 |
| Multiple pulmonary nodules: an unusual presentation of fludarabine pulmonary toxicity: case report and review of literature. | American journal of hematology 20020701 |
| Cast nephropathy in a case of Waldenström's macroglobulinemia. | Nephron 20020701 |
| Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia. | European journal of haematology 20020701 |
| [Experience with fludarabine treatment and review of the literature]. | Orvosi hetilap 20020616 |
| Release of snRNP and RNA from transcription sites in adenovirus-infected cells. | Experimental cell research 20020610 |
| Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone. | Haematologica 20020601 |
| Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. | Leukemia 20020601 |
| Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. | Leukemia 20020601 |
| Challenges in treating hematologic malignancies. | Seminars in oncology 20020601 |
| Tetrasomy 13 as the sole cytogenetic abnormality in acute myeloid leukemia M1 without maturation. | Cancer genetics and cytogenetics 20020601 |
| Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia. | Clinical lymphoma 20020601 |
| Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. | Clinical lymphoma 20020601 |
| Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. | Blood 20020515 |
| CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia. | Leukemia research 20020501 |
| Conjugates of nucleoside analogs with lactosaminated human albumin to selectively increase the drug levels in liver blood: requirements for a regional chemotherapy. | The Journal of pharmacology and experimental therapeutics 20020501 |
| Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms. | The American journal of surgical pathology 20020501 |
| Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues. | American journal of hematology 20020501 |
| Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease. | American journal of hematology 20020501 |
| Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies. | Cancer 20020501 |
| Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia. | Annals of hematology 20020501 |
| Fludarabine-induced eosinophilia: case report. | Annals of hematology 20020501 |
| Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay. | Japanese journal of cancer research : Gann 20020501 |
| A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20020501 |
| Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy. | The Netherlands journal of medicine 20020501 |
| Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population. | Cancer 20020401 |
| Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia. | Leukemia 20020401 |
| Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine. | Bone marrow transplantation 20020401 |
| Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases. | Pathology 20020401 |
| Immunochemotherapy in indolent non-Hodgkin's lymphoma. | Seminars in oncology 20020401 |
| [Fludarabine as primary therapeutic drug in chronic lymphatic leukemia]. | Der Internist 20020401 |
| De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG). | European journal of haematology 20020401 |
| [Mother-infant and indirect transmission of HSV infection: treatment and prevention]. | Annales de dermatologie et de venereologie 20020401 |
| [Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)]. | Annales de dermatologie et de venereologie 20020401 |
| [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20020401 |
| Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders. | Leukemia & lymphoma 20020401 |
| Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia. | Blood 20020315 |
| Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. | Blood 20020315 |
| Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. | Journal of leukocyte biology 20020301 |
| High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma. | British journal of haematology 20020301 |
| Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma. | Clinical lymphoma 20020301 |
| Correlation between chromosome damage and apoptosis induced by fludarabine and idarubicin in normal human lymphocytes. | Toxicology 20020227 |
| Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. | Blood 20020201 |
| Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. | Haematologica 20020201 |
| Hematopoietic cell transplantation beyond first remission. | Leukemia 20020201 |
| Non-myeloablative bone marrow transplantation in an adult with Wiskott-Aldrich syndrome. | British journal of haematology 20020201 |
| Rituximab in combination with CHOP or fludarabine in low-grade lymphoma. | Seminars in oncology 20020201 |
| Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone. | Seminars in oncology 20020201 |
| Emerging information on the use of rituximab in chronic lymphocytic leukemia. | Seminars in oncology 20020201 |
| Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma. | Cancer 20020201 |
| Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine. | Leukemia & lymphoma 20020201 |
| Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. | Leukemia & lymphoma 20020201 |
| Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication? | European journal of haematology 20020201 |
| Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma. | European journal of haematology 20020201 |
| Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. | Blood 20020115 |
| Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. | Blood 20020101 |
| Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. | Experimental hematology 20020101 |
| Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma. | International journal of hematology 20020101 |
| Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. | Annals of oncology : official journal of the European Society for Medical Oncology 20020101 |
| Cellular and clinical pharmacology of fludarabine. | Clinical pharmacokinetics 20020101 |
| Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer. | Cancer treatment and research 20020101 |
| Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation. | Cancer treatment and research 20020101 |
| Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group. | Leukemia & lymphoma 20020101 |
| Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen. | European journal of haematology 20020101 |
| Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. | Health technology assessment (Winchester, England) 20020101 |
| Dimethyl sulfoxide blocks herpes simplex virus-1 productive infection in vitro acting at different stages with positive cooperativity. Application of micro-array analysis. | BMC infectious diseases 20020101 |
| Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture. | BMC microbiology 20020101 |
| [Peripheral blood hematopoietic cell transplant using immunosuppressive chemotherapy without bone marrow destruction: 'minitransplant']. | Gaceta medica de Mexico 20020101 |
| Current and developing chemotherapy for CLL. | Medical oncology (Northwood, London, England) 20020101 |
| Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation. | Cytotherapy 20020101 |
| Waldenström's macroglobulinemia. | Clinical journal of oncology nursing 20020101 |
| Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101 |
| The role of membrane transporters in cellular resistance to anticancer nucleoside drugs. | Cancer treatment and research 20020101 |
| Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia. | Medical oncology (Northwood, London, England) 20020101 |
| High molecular weight DNA fragmentation assay: a sensitive method for monitoring in vivo response to antileukemic chemotherapy. | Anticancer research 20020101 |
| Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia. | Annals of hematology 20020101 |
| Facial paresis after fludarabine treatment for advanced chronic lymphocytic leukaemia. | Haematologia 20020101 |
| Analysis of recurrent failure times data: should the baseline hazard be stratified? | Statistics in medicine 20011230 |
| Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts. | Blood 20011215 |
| Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. | Blood 20011215 |
| Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. | Blood 20011215 |
| Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. | Blood 20011201 |
| Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant. | British journal of haematology 20011201 |
| Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. | British journal of haematology 20011201 |
| Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes. | Leukemia 20011201 |
| Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation. | British journal of haematology 20011201 |
| Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir. | The Journal of general virology 20011101 |
| Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease. | Blood 20011101 |
| Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease. | Haematologica 20011101 |
| Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. | Haematologica 20011101 |
| DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011101 |
| [Chronic lymphocytic leukemias]. | Nihon rinsho. Japanese journal of clinical medicine 20011101 |
| Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses. | Journal of medicinal chemistry 20011025 |
| High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens. | Cancer 20011015 |
| Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia. | Cancer 20011015 |
| Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis. | Leukemia 20011001 |
| Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan. | Haematologica 20011001 |
| Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation. | The Journal of rheumatology. Supplement 20011001 |
| Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient. | Journal of thoracic imaging 20011001 |
| Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine. | Thrombosis and haemostasis 20011001 |
| A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. | Bone marrow transplantation 20011001 |
| Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. | Bone marrow transplantation 20011001 |
| Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. | British journal of haematology 20011001 |
| Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis. | British journal of haematology 20011001 |
| Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders. | Annals of oncology : official journal of the European Society for Medical Oncology 20011001 |
| The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning. | Bone marrow transplantation 20011001 |
| Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure. | Bone marrow transplantation 20011001 |
| Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis. | Leukemia 20010901 |
| Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation. | Haematologica 20010901 |
| Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis. | Journal of neuropathology and experimental neurology 20010901 |
| Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone. | British journal of haematology 20010901 |
| Therapeutic options for acute myelogenous leukemia. | Cancer 20010901 |
| Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant. | Bone marrow transplantation 20010901 |
| Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. | Annals of hematology 20010901 |
| Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report. | Annals of hematology 20010901 |
| Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010815 |
| Erythroleukaemia in the north of England: a population based study. | Journal of clinical pathology 20010801 |
| Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010801 |
| Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. | British journal of haematology 20010801 |
| Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. | Bone marrow transplantation 20010801 |
| Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia. | Onkologie 20010801 |
| [Drug-induced hemolytic anemia]. | Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010801 |
| Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant? | Transplantation 20010727 |
| Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells. | Biochemical pharmacology 20010701 |
| Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). | Blood 20010701 |
| Herpes simplex virus dermatitis in patients using latanoprost. | American journal of ophthalmology 20010701 |
| Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis. | Journal of clinical epidemiology 20010701 |
| Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia. | British journal of haematology 20010701 |
| Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning. | Bone marrow transplantation 20010701 |
| Acute left ventricular failure following melphalan and fludarabine conditioning. | Bone marrow transplantation 20010701 |
| Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning. | Bone marrow transplantation 20010701 |
| Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation. | Bone marrow transplantation 20010701 |
| Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation. | International journal of hematology 20010701 |
| Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia. | Leukemia & lymphoma 20010701 |
| Novel therapies in vasculitis. | Expert opinion on investigational drugs 20010701 |
| Management of genital herpes in HIV-infected patients. | Herpes : the journal of the IHMF 20010701 |
| [Chronic lymphocytic leukemia. 2. Therapy]. | Deutsche medizinische Wochenschrift (1946) 20010608 |
| [Chronic lymphatic leukemia. 3. The concrete case]. | Deutsche medizinische Wochenschrift (1946) 20010608 |
| UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism. | Experimental hematology 20010601 |
| Nucleoside analogues: mechanisms of drug resistance and reversal strategies. | Leukemia 20010601 |
| Paraneoplastic pemphigus: an association with fludarabine? | The British journal of dermatology 20010601 |
| Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. | Annals of the New York Academy of Sciences 20010601 |
| Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias. | Annals of hematology 20010601 |
| Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. | Journal of experimental & clinical cancer research : CR 20010601 |
| Non-myeloablative hematopoietic stem cell transplantation. | Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010601 |
| Combination chemotherapy and rituximab. | Anti-cancer drugs 20010601 |
| Nucleoside analogues in the treatment of haematological malignancies. | Expert opinion on pharmacotherapy 20010601 |
| Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues. | Expert opinion on pharmacotherapy 20010601 |
| Features of the engraftment of allogeneic hematopoietic stem cells using reduced-intensity conditioning regimens. | Leukemia & lymphoma 20010601 |
| Novel treatment strategies in chronic lymphocytic leukemia. | Current oncology reports 20010501 |
| Contact dermatitis from topical antiviral drugs. | Contact dermatitis 20010501 |
| Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010501 |
| Fatal legionella pneumonia after fludarabine treatment in chronic lymphocytic leukaemia. | Journal of clinical pathology 20010501 |
| Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis. | Pharmacotherapy 20010501 |
| A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma. | The British journal of dermatology 20010501 |
| Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20010501 |
| [Molecular biology examination in chronic lymphocytic leukemia]. | Orvosi hetilap 20010422 |
| Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415 |
| Fludarabine for chronic lymphocytic leukemia. | The New England journal of medicine 20010412 |
| Fludarabine for chronic lymphocytic leukemia. | The New England journal of medicine 20010412 |
| Fludarabine for chronic lymphocytic leukemia. | The New England journal of medicine 20010412 |
| Fludarabine for chronic lymphocytic leukemia. | The New England journal of medicine 20010412 |
| Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol. | Blood 20010401 |
| Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens. | American journal of hematology 20010401 |
| Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis. | Archives of disease in childhood 20010401 |
| Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. | Clinical microbiology reviews 20010401 |
| Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia. | Leukemia & lymphoma 20010401 |
| [Mantle cell lymphoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20010401 |
| Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine. | Onkologie 20010401 |
| Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients. | Bone marrow transplantation 20010401 |
| Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases. | Clinical and laboratory haematology 20010401 |
| Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010301 |
| Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma. | Haematologica 20010301 |
| Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis. | British journal of haematology 20010301 |
| New drug combinations for the treatment of murine AIDS and macrophage protection. | European journal of clinical investigation 20010301 |
| Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. | Experimental hematology 20010301 |
| Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia. | Bone marrow transplantation 20010301 |
| Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation. | Bone marrow transplantation 20010301 |
| Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma. | Leukemia & lymphoma 20010301 |
| Reversal of fludarabine induced testicular damage in a patient with chronic lymphocytic leukaemia (CLL), by suppression of pituitary-testicular axis using gonadotrophin releasing hormone (GnRH). | Leukemia & lymphoma 20010301 |
| Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. | Blood 20010201 |
| Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment. | British journal of haematology 20010201 |
| Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation. | British journal of haematology 20010201 |
| A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment. | British journal of haematology 20010201 |
| Bilateral breast relapse in acute myelogenous leukemia. | Journal of pediatric hematology/oncology 20010201 |
| Reactivation of hepatitis B virus infection during cytotoxic chemotherapy. | The American journal of gastroenterology 20010201 |
| Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010201 |
| Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment. | Leukemia & lymphoma 20010201 |
| Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma. | Leukemia & lymphoma 20010201 |
| Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma. | Leukemia research 20010101 |
| Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report. | Haematologica 20010101 |
| Red swollen nail folds and nail deformity as presenting findings in chronic lymphocytic leukaemia. | British journal of haematology 20010101 |
| A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. | British journal of haematology 20010101 |
| Antiviral drugs in chronic hepatitis B: review and meta-analysis. | International journal of clinical pharmacology and therapeutics 20010101 |
| Results of IDA-FLAG programme in the treatment of recurrent acute myeloblastic leukaemia--preliminary report. | Medical science monitor : international medical journal of experimental and clinical research 20010101 |
| Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells. | Leukemia 20010101 |
| Management of neonatal herpes simplex virus infection. | Paediatric drugs 20010101 |
| Interventions for herpes simplex virus epithelial keratitis. | The Cochrane database of systematic reviews 20010101 |
| A fludarabine-based conditioning regimen for severe aplastic anemia. | Bone marrow transplantation 20010101 |
| Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20010101 |
| Second allogeneic peripheral blood stem cell transplantation with fludarabine-based low-intensity conditioning regimen for relapsed myelodysplastic syndrome after allogeneic bone marrow transplantation. | International journal of hematology 20010101 |
| Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. | Acta haematologica 20010101 |
| Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma. | Journal of cancer research and clinical oncology 20010101 |
| Treatment of 'poor risk' acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study. | Leukemia & lymphoma 20010101 |
| First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia. | Leukemia & lymphoma 20010101 |
| Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimen. | Leukemia & lymphoma 20010101 |
| Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia. | Leukemia & lymphoma 20010101 |
| A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia. | Acta oncologica (Stockholm, Sweden) 20010101 |
| Vidarabine therapy for severe chronic active Epstein-Barr virus infection. | Journal of pediatric hematology/oncology 20010101 |
| Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101 |
| Recombinant bacterial cells as efficient biocatalysts for the production of nucleosides. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma. | Leukemia & lymphoma 20010101 |
| Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma. | Leukemia & lymphoma 20010101 |
| A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors. | Leukemia & lymphoma 20010101 |
| Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies. | The oncologist 20010101 |
| Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern. | European journal of dermatology : EJD 20010101 |
| Chronic lymphocytic leukaemia. | Clinical medicine (London, England) 20010101 |
| Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells. | Anticancer research 20010101 |
| [Lupus nephritis: treatments for today and tomorrow]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101 |
| [Nucleoside analogues--new drugs for the treatment of lymphatic cancers]. | Duodecim; laaketieteellinen aikakauskirja 20010101 |
| In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. | Cytotherapy 20010101 |
| [Non-myeloablative therapy and allogeneic hematopoietic stem cell transplantation in hematologic malignancies]. | Polskie Archiwum Medycyny Wewnetrznej 20010101 |
| Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. | The New England journal of medicine 20001214 |
| Anti-human immunodeficiency virus type 1 (HIV-1) activity of 2'-fluoro-2',3'-dideoxyarabinosyladenine (F-ddA) used in combination with other mechanistically diverse inhibitors of HIV-1 replication. | Antiviral chemistry & chemotherapy 19990501 |
| Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. | Blood 19981115 |
| Efficacy of select antivirals against Cryptosporidium parvum in vitro. | FEMS microbiology letters 19981101 |
| Anti-herpesvirus activity profile of 4'-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-beta-D-2'-fluoro-4'-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus. | Antiviral research 19980801 |
| Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. | Hematology and cell therapy 19980601 |
| Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells. | Anticancer research 19980101 |
| A facile, alternative synthesis of 4'-thioarabinonucleosides and their biological activities. | Journal of medicinal chemistry 19970704 |
| Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds. | Antimicrobial agents and chemotherapy 19950701 |
| Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 19950401 |
| Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells. | Leukemia 19941201 |
| Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells. | American journal of hematology 19941201 |
| Pentostatin increases the acute toxicity of high dose cyclophosphamide. | Bone marrow transplantation 19930901 |
| Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia. | Leukemia & lymphoma 19930301 |
| Neurotoxicity associated with fludarabine and cytosine arabinoside chemotherapy for acute leukemia and myelodysplasia. | Leukemia 19930301 |
| Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. | The Journal of rheumatology 19930201 |
| Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. | Antiviral research 19920701 |
| Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine. | Journal of medicinal chemistry 19920124 |
| In vitro antiviral activity of polyoxotungstate (PM-19) and other polyoxometalates against herpes simplex virus. | Antiviral research 19911201 |
| 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus. | Antimicrobial agents and chemotherapy 19910501 |
| Synthesis and antimicrobial and cytotoxic activities of pyrrole-containing analogues of trichostatin A. | Journal of medicinal chemistry 19901001 |
| Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro. | Antimicrobial agents and chemotherapy 19900701 |
| Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS. | Journal of medicinal chemistry 19900501 |
| Synthesis and biological evaluation of carbocyclic analogues of lyxofuranosides of 2-amino-6-substituted-purines and 2-amino-6-substituted-8-azapurines. | Journal of medicinal chemistry 19900401 |
| Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. | Journal of medicinal chemistry 19890701 |
| Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides. | Journal of medicinal chemistry 19890201 |
| (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. | Antimicrobial agents and chemotherapy 19881201 |
| 7-Aminoquinolines. A novel class of agents active against herpesviruses. | Journal of medicinal chemistry 19880701 |
| Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells. | Antimicrobial agents and chemotherapy 19880701 |
| Synthesis and antiviral activity of carbocyclic analogues of xylofuranosides of 2-amino-6-substituted-purines and 2-amino-6-substituted-8-azapurines. | Journal of medicinal chemistry 19871101 |
| 2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV). | Biochemical pharmacology 19870901 |
| Synthesis and antiviral evaluation of carbocyclic analogues of 2-amino-6-substituted-purine 3'-deoxyribofuranosides. | Journal of medicinal chemistry 19870601 |
| Drug combinations for treatment of mice infected with acyclovir-resistant herpes simplex virus. | Antimicrobial agents and chemotherapy 19870301 |
| Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro. | Antimicrobial agents and chemotherapy 19870201 |
| Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo. | Antimicrobial agents and chemotherapy 19870101 |
| Severe hepatic failure after ARA-A-prednisolone for chronic type B hepatitis. | Gastroenterology 19870101 |
| Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures. | Antimicrobial agents and chemotherapy 19861201 |
| Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis. | Antimicrobial agents and chemotherapy 19860901 |
| In vitro activity of ketoconazole against herpes simplex virus. | Antimicrobial agents and chemotherapy 19860801 |
| Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV). | International journal of cancer 19860315 |
| Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. | Proceedings of the National Academy of Sciences of the United States of America 19860301 |
| Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. | Antiviral research 19860301 |
| Synthesis and antiviral activity of the carbocyclic analogues of 5-ethyl-2'-deoxyuridine and of 5-ethynyl-2'-deoxyuridine. | Journal of medicinal chemistry 19860101 |
| Comparative efficacy of broad-spectrum antiviral agents as inhibitors of rotavirus replication in vitro. | Antiviral research 19860101 |
| 5-(Haloalkyl)-2'-deoxyuridines: a novel type of potent antiviral nucleoside analogue. | Journal of medicinal chemistry 19851101 |
| Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses. | Antiviral research 19850201 |
| Synthesis and antiviral activity of carbocyclic analogues of 2'-deoxyribofuranosides of 2-amino-6-substituted-purines and of 2-amino-6-substituted-8-azapurines. | Journal of medicinal chemistry 19841101 |
| Synthesis and antiviral evaluation of carbocyclic analogues of ribofuranosides of 2-amino-6-substituted-purines and of 2-amino-6-substituted-8-azapurines. | Journal of medicinal chemistry 19840501 |
| Synthesis and evaluation of a series of 2'-O-acyl derivatives of 9-beta-D-arabinofuranosyladenine as antiherpes agents. | Journal of medicinal chemistry 19840301 |
| Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice. | Antimicrobial agents and chemotherapy 19831001 |
| Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine-5'-monophosphate with adenine arabinoside-5'-monophosphate. | Antiviral research 19830901 |
| Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirus. | Antimicrobial agents and chemotherapy 19830901 |
| Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus. | Antimicrobial agents and chemotherapy 19830701 |
| Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes. | Antimicrobial agents and chemotherapy 19830601 |
| Carbocyclic analogues of 5-substituted uracil nucleosides: synthesis and antiviral activity. | Journal of medicinal chemistry 19830201 |
| Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice. | Antimicrobial agents and chemotherapy 19820901 |
| Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs. | Antiviral research 19820501 |
| In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. | Molecular pharmacology 19820301 |
| In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. | Antimicrobial agents and chemotherapy 19820101 |
| Synthesis and antiherpetic activity of some 4-[(aryloxy)alkyl]pyrazoles. | Journal of medicinal chemistry 19810601 |
| Synthesis and antiviral activity of 5-[(cyanomethylene)oxy]-2'-deoxyuridine. | Journal of medicinal chemistry 19810401 |
| Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection. | Antimicrobial agents and chemotherapy 19810301 |
| In vitro susceptibility of varicella-zoster virus to acyclovir. | Antimicrobial agents and chemotherapy 19800901 |
| Antiviral, antimetabolic and antineoplastic activities of 2'- or 3'-amino or -azido-substituted deoxyribonucleosides. | Biochemical pharmacology 19800615 |
| Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2. | Antimicrobial agents and chemotherapy 19800401 |
| In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). | Antimicrobial agents and chemotherapy 19800201 |
| Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice. | Antimicrobial agents and chemotherapy 19791101 |
| Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine. | Biochemical pharmacology 19790701 |
| (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. | Proceedings of the National Academy of Sciences of the United States of America 19790601 |
| Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells. | Antimicrobial agents and chemotherapy 19790101 |
| Effect of 9-(2-hydroxyethoxymethyl)guanine on herpesvirus-induced keratitis and iritis in rabbits. | Antimicrobial agents and chemotherapy 19781201 |
| Trisodium phosphonoformate, a new antiviral compound. | Science (New York, N.Y.) 19780901 |
| 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. | Nature 19780413 |
| 5-O-Alkylated derivatives of 5-hydroxy-2'-deoxyuridine as potential antiviral agents. Anti-herpes activity of 5-propynyloxy-2'-deoxyuridine. | Journal of medicinal chemistry 19780201 |
| Improved synthesis and in vitro antiviral activities of 5-cyanouridine and 5-cyano-2'-deoxyuridine. | Journal of medicinal chemistry 19770701 |
| Antiviral activity of some beta-diketones. 1. Aryl alkyl diketones. In vitro activity against both RNA and DNA viruses. | Journal of medicinal chemistry 19770601 |
| Antiviral activity of some beta-diketones. 2. Aryloxy alkyl diketones. In vitro activity against both RNA and DNA viruses. | Journal of medicinal chemistry 19770601 |
| Antiviral activity of O'-methylated derivatives of adenine arabinoside. | Biochemical pharmacology 19770415 |
| Carbocyclic arabinosyladenine, an adenosine deaminase resistant antiviral agent. | Journal of medicinal chemistry 19770401 |
| Antiviral activities of acyl derivatives of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosylcytosine in cell culture. | Antimicrobial agents and chemotherapy 19770201 |
| Effect of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on experimental herpes simplex keratitis. | Antimicrobial agents and chemotherapy 19761201 |
| Synthesis and anti-DNA -virus activity of the 5'-monophosphate and the cyclic 3',5'-monophosphate of 9-(beta-D-xylofuranosyl) guanine. | Journal of medicinal chemistry 19760801 |
| In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside. | Antimicrobial agents and chemotherapy 19760301 |
| Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures. | Antimicrobial agents and chemotherapy 19760101 |
| Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus. | Antimicrobial agents and chemotherapy 19741101 |
| Treatment of poxvirus infections in rabbits with 9-beta-D-arabinofuranosyladenine. | Antimicrobial agents and chemotherapy 19740401 |
| Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds. | Antimicrobial agents and chemotherapy 19740301 |
| Nucleic acids. 14. Synthesis and antiviral activity of some 5'-esters of 9-beta-D-arabinofuranosyladenine (ara-A). | Journal of medicinal chemistry 19730701 |
| In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. | Antimicrobial agents and chemotherapy 19730201 |
| Azapurine nucleosides. 2. Synthesis and antiviral activity of 7-amino-3- -D-arabinofuranosyl-v-triazolo (4,5-d)pyrimidine and related nucleosides. | Journal of medicinal chemistry 19720901 |
| Purine analogs as potential anticytomegalovirus agents. | Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 19690901 |
| The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A). | Chemotherapia 19680101 |
| Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice. | Antimicrobial agents and chemotherapy 19680101 |